syndrome	score	normalized_score
DRAVET SYNDROME	2.6698290399999993	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	56.96023330392722
MYOCLONIC-ASTASTIC EPILEPSY	1.223545494	45.82860833665965
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	44.710503261287485
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	43.314631112110476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.47586096374172
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.45558180009909
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.45558180009909
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.000022323526764
LAFORA DISEASE	0.77152896	28.898066072425383
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.863911825605143
CRANIOSYNOSTOSIS 4; CRS4	0.75406504	28.24394478831499
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.038460619935428
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.545853812422394
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.688410474	25.78481482095199
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59705175	22.36292066101731
ROLANDIC EPILEPSY	0.5906213	22.122064415030867
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.80865822030313
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	19.97629780819225
MENINGIOMA	0.5277778	19.768224560176336
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.740102909360825
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.35880748379305
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5135696	19.23604816284417
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.991562470981293
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.748224942522917
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.500545554	18.748224942522917
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.727790900049545
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.727790900049545
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.5	18.727790900049545
CREST SYNDROME	0.5	18.727790900049545
PAROXYSMAL HEMICRANIA	0.5	18.727790900049545
TRICHODENTOOSSEOUS SYNDROME	0.5	18.727790900049545
INHALATIONAL ANTHRAX	0.5	18.727790900049545
TRICHO-DENTO-OSSEOUS SYNDROME	0.5	18.727790900049545
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42505119	15.920539616274462
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41513130400000003	15.548984514753803
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.315261534498859
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.3883698099999999	14.54661718714394
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.654803530041763
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.391031959110014
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.391031959110014
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.285528574518768
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.34968319400000003	13.097587476986922
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.348573844	13.05603612731698
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.91570714205731
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.831992418510815
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.748953019104178
COG4-CDG	0.333878554	12.505615490645802
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.48518144817243
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.48518144817243
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.48518144817243
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31997625	11.984896605963957
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.284670646926518
DOORS SYNDROME	0.29093556400000004	10.897160815959966
DYSTONIA 6, TORSION	0.2635135	9.870051454680413
PALLISTER-HALL SYNDROME	0.261290384	9.786783351491302
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.259940294	9.736214945058808
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25327035400000003	9.486388461787056
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.252506059	9.457761347895147
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.252176874	9.445431532200281
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	9.43748218425252
NIJMEGEN BREAKAGE SYNDROME	0.25	9.363895450024772
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.363895450024772
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.25	9.363895450024772
HYPERPARATHYROIDISM 2	0.25	9.363895450024772
HYPEREKPLEXIA 1; HKPX1	0.25	9.363895450024772
OTOFACIOCERVICAL SYNDROME 2	0.25	9.363895450024772
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.25	9.363895450024772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.103397646764682
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23908618000000004	8.955111972263216
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.787633982736216
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.711093726061204
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.462307758851857
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.216847064	8.122132943763322
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21135259	7.916334223407804
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.805869097895498
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.685447155073273
6P22 MICRODELETION SYNDROME	0.20163132	7.552218399721957
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.491116360019818
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.491116360019818
JUVENILE HYALINE FIBROMATOSIS	0.2	7.491116360019818
BETA-THALASSEMIA	0.2	7.491116360019818
INFANTILE MYOFIBROMATOSIS	0.2	7.491116360019818
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.093778184388917
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18559615399999999	6.951611927930787
MYOCLONIC EPILEPSY OF INFANCY	0.18559615399999999	6.951611927930787
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.853446316547671
AURICULOOSTEODYSPLASIA	0.17473152	6.544670740415651
AURICULOOSTEODYSPLASIA	0.17473152	6.544670740415651
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.171434473	6.421177926808379
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.383538101001404
MICROTRIPLICATION 11Q24.1	0.1693918	6.344668421166025
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.16926173400000002	6.339796723463614
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.168466454	6.31000904836963
UNILATERAL POLYMICROGYRIA	0.16800169999999998	6.292601416905706
BRANCHIOSKELETOGENITAL SYNDROME	0.167208419	6.262888615519743
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.974378793932066
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.974378793932066
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15945895	5.97262774548291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.801751785575005
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.718037062028512
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.718037062028512
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.677947828449721
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.15155264999999998	5.6764926790967865
LÉRI-WEILL DYSCHONDROSTEOSIS	0.14959561999999998	5.603190981846539
DISTAL MONOSOMY 7Q36	0.14612321899999997	5.473130182148292
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14520144999999998	5.438604787967997
PIEBALDISM	0.14482163999999997	5.424378783444501
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.371226091690127
PACMAN DYSPLASIA	0.14285699999999998	5.350792049216755
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.350792049216755
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.14285699999999998	5.350792049216755
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	5.350792049216755
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.350792049216755
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.152640934642018
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.123509855896993
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.962066784620787
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12522615399999998	4.690418454658805
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.12406020000000001	4.646746969236654
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12231927000000001	4.581539423213407
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.425498720322557
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.2360502603567465
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.11157119400000001	4.178963983401726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.11106920400000002	4.160161655893893
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.10689451999999999	4.003796437842328
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10576764	3.9615884918234325
BILATERAL POLYMICROGYRIA	0.10466076400000002	3.920129807262867
AICARDI SYNDROME; AIC	0.1036867	3.8836456734323344
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10044303400000001	3.7621522762371344
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7063460812457127
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.6853990471240072
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.675210979052053
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.675210979052053
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.09720319399999999	3.640802184097901
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.09636237	3.6093086319864147
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08992909	3.368346386703473
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.08122672	3.042394055313745
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9605944356646905
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.077789744	2.913660119600767
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.901633506840574
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.901633506840574
TURNPENNY-FRY SYNDROME; TPFS	0.077216954	2.892205936901489
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8811994643672025
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.858201737141942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07628449400000001	2.8572801050961685
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07573894	2.836846062622797
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07485825	2.8038593062872676
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.734408791957706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.6958338126399295
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.6792052572774483
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.675399770166558
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.071273159	2.6695776370759687
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6510836064619334
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07073174	2.649298473433341
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.5737932643057926
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.5737932643057926
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.517474077666037
ATELOSTEOGENESIS TYPE II	0.0668384	2.503471158587743
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.497040035192666
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.497040035192666
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.497040035192666
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.497040035192666
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.497040035192666
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.497040035192666
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.497040035192666
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.497040035192666
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.497040035192666
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.497040035192666
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.066093433	2.4755679861808684
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.065901773	2.4683892493730615
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4276760432570628
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4276760432570628
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.064030564	2.3983020276084797
HOLMES-GANG SYNDROME	0.063504124	2.3785839111256357
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3446388911853333
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.061868669	2.317326992592755
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.061868669	2.317326992592755
611961 STEVENSON-CAREY SYNDROME	0.061783093	2.3141216937246294
PENILE AGENESIS	0.06132725	2.297047828950127
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.060411494	2.2627476551831958
49,XXXYY SYNDROME	0.0602926	2.258294411240654
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.05874582	2.200358866423897
WHITE-SUTTON SYNDROME; WHSUS	0.058150334	2.178054591840083
15Q13.3 MICRODELETION SYNDROME	0.058074693	2.175221414177142
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.164105234243763
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.057314533	2.1467491791159787
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05694194	2.1327934915263342
2P15P16.1 MICRODELETION SYNDROME	0.056773114	2.126470015473351
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.056773114	2.126470015473351
2Q23.1 MICRODUPLICATION SYNDROME	0.055901954000000004	2.0938402108323766
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0808673202535855
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0808673202535855
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0808673202535855
GITELMAN SYNDROME	0.055555600000000004	2.0808673202535855
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0808673202535855
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0808673202535855
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0808673202535855
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0808673202535855
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0808673202535855
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0808673202535855
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.055222199	2.0683795918258503
MOWAT-WILSON SYNDROME; MOWS	0.055137659	2.06521309694047
BAKER-GORDON SYNDROME; BAGOS	0.054808474	2.052883281245604
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.054804339	2.0527284024148607
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.05426292	2.032449238772233
POTOCKI-LUPSKI SYNDROME	0.053718573	2.0120604051860944
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.053177154	1.9917812415434666
KEPPEN-LUBINSKY SYNDROME	0.053173019	1.9916263627127233
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.053173019	1.9916263627127233
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05286995	1.9802747369921487
THREE M SYNDROME 2; 3M2	0.0526316	1.9713471990700953
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.0526316	1.9713471990700953
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.0526316	1.9713471990700953
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.9713471990700953
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.9713471990700953
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0526316	1.9713471990700953
CHROMOSOME 1P36 DELETION SYNDROME	0.051879933	1.9431930742651604
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9207677057853867
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.917018589325106
AICARDI SYNDROME	0.05084892	1.9045758825066945
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.83820211948852
ADNP SYNDROME	0.048677239000000004	1.8232343071674737
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0475633	1.781511073832653
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.04592198399999999	1.720034628134841
DISTAL MONOSOMY 12Q	0.04493705399999999	1.6831435019524696
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6827111147161695
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297954	1.6592056396240267
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.043986594000000004	1.647543469674748
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.6205818182275824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6199072431993626
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.601471456015027
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.601471456015027
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.5994732007259913
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.042599213999999996	1.5955783445969263
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.04236914	1.5869607890698503
PITT-HOPKINS-LIKE SYNDROME	0.042317719	1.5850347855981075
WITTEVEEN-KOLK SYNDROME	0.042292453	1.5840884328683462
COG2-CDG	0.04221225399999999	1.5810845326635596
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.04190499400000001	1.5695759305996617
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.04134734	1.5486886755865092
CANAVAN DISEASE	0.04134734	1.5486886755865092
CHRISTIANSON SYNDROME	0.04134734	1.5486886755865092
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5458350846314866
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.04126499	1.545604208425271
AARSKOG-SCOTT SYNDROME	0.040165493999999996	1.504421946058389
ALPERS-HUTTENLOCHER SYNDROME	0.039675944	1.4860855659881507
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.03961994	1.4839879035850179
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4720174741975243
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4709593540116717
TRICHOTHIODYSTROPHY	0.039213873999999996	1.4687784653057787
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038925144	1.4579639151726365
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03857886	1.4449936464845707
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4428377031961568
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.038470234	1.4409249964559532
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03837959	1.437529872699265
HELSMOORTEL-VAN DER AA SYNDROME	0.038366652999999994	1.4370453098375169
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4189395437844217
LISSENCEPHALY 2; LIS2	0.037582554	1.4076764256036411
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.4076764256036411
16P13.11 MICRODELETION SYNDROME	0.037582554	1.4076764256036411
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.38724238313027
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.38724238313027
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.38724238313027
MCLEOD SYNDROME; MCLDS	0.037037	1.38724238313027
MYOCLONUS AND ATAXIA	0.037037	1.38724238313027
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.38724238313027
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.036868693999999994	1.3809383839798222
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765933	1.3770894109384626
WEST SYNDROME	0.03656844	1.3696921957220156
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.036484994	1.3665666772431246
LUSCAN-LUMISH SYNDROME; LLS	0.036402013	1.3634585756097704
THUMBS, CONGENITAL CLASPED	0.0361093	1.352494839894318
WOLF-HIRSCHHORN SYNDROME	0.03593293299999999	1.3458889112989798
15Q24 MICRODELETION SYNDROME	0.03593293299999999	1.3458889112989798
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.035842320000000004	1.3424949486653277
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.335900144377784
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.335900144377784
JUVENILE ABSENCE EPILEPSY	0.03566625	1.335900144377784
TEMPLE-BARAITSER SYNDROME	0.035387379	1.3254548688256085
RAMOS-ARROYO SYNDROME	0.03531504	1.3227453694937714
15Q26 OVERGROWTH SYNDROME	0.03526382	1.3208268945939703
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3042052310585406
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3042052310585406
TRISOMY 17P	0.034520353999999996	1.2929799430153777
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.034520353999999996	1.2929799430153777
PEHO SYNDROME	0.034434974	1.2897819854412855
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2760835802430257
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.033889419999999996	1.269347942967914
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.033844733999999994	1.2676742028395946
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.033760194	1.2645077079542144
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.033426873999999995	1.2520230134286052
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.03329918	1.2472401603662235
NOONAN SYNDROME 4; NS4	0.03288132	1.2315889709552341
OROFACIAL CLEFT 15	0.03288132	1.2315889709552341
3P25.3 MICRODELETION SYNDROME	0.032858229999999995	1.2307241215714697
SLC35A2-CDG	0.032803653999999995	1.2286799457391475
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2285250669084042
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2285250669084042
TUBEROUS SCLEROSIS-1	0.032799519	1.2285250669084042
PIERPONT SYNDROME	0.032336973	1.2112001373690955
WIEACKER-WOLFF SYNDROME	0.032336973	1.2112001373690955
ALG13-CDG	0.0322581	1.2082459032657764
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2082459032657764
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03208814	1.2018799525830317
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.031795554	1.1909209737264677
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.031795554	1.1909209737264677
XP22.13P22.2 DUPLICATION SYNDROME	0.031791419	1.1907660948957244
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.03125	1.1704869312530966
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.03125	1.1704869312530966
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.03125	1.1704869312530966
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1696220818693321
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1128417795620353
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.02907618	1.0890652384244053
CHROMOSOME 17Q12 DELETION SYNDROME	0.028658319999999998	1.0734140490134156
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0721285734460362
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0721285734460362
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0615422776283836
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0615422776283836
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0608677026001638
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0608677026001638
8Q24.3 MICRODELETION SYNDROME	0.028232942999999996	1.057481305994035
GANGLIOCYTOMA	0.027777800000000002	1.0404336601267927
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0404336601267927
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0404336601267927
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0404336601267927
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0327460517846494
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.032591172953906
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.027535599	1.0313618807592269
AYMÉ-GRIPP SYNDROME	0.027495253999999997	1.0298507353115016
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.027442293999999996	1.0278670876993683
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.012312009311278
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	1.012312009311278
BENIGN OCCIPITAL EPILEPSY	0.027027	1.012312009311278
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.012312009311278
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.012312009311278
CONGENITAL TRACHEAL STENOSIS	0.02593705	0.97148729792826
DISTAL MONOSOMY 10Q	0.025924793	0.9710282048621363
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.025664603999999997	0.9612826744891503
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.025609454	0.959216999152875
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9262845534109556
19P13.3 MICRODUPLICATION SYNDROME	0.023939994	0.8966864035608815
PENTASOMY X	0.023825814	0.8924097252309461
HAREL-YOON SYNDROME; HAYOS	0.023535473999999997	0.8815348716111053
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023392444	0.8761775997462371
SALT-AND-PEPPER SYNDROME	0.023392444	0.8761775997462371
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.022989919999999997	0.8611008291377339
AMISH INFANTILE EPILEPSY SYNDROME	0.022846889999999998	0.8557435572728658
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.022601589999999998	0.8465557030573014
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8432451540043179
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8432451540043179
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8432451540043179
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8432451540043179
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.022402593000000002	0.8391021546458273
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.022209149999999997	0.8318566345356706
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8228111115309467
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.02157802	0.8082172931941741
ZUNICH NEUROECTODERMAL SYNDROME	0.021453518999999997	0.8035540358044799
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7972946462519565
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.02116405	0.7927118059963871
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.021101303999999998	0.790361618060758
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.021096879	0.7901958771112926
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021045054	0.7882547415845025
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.020910783000000002	0.7832255431606215
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7802949060738363
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7768606037785851
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7768606037785851
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7768606037785851
X SMALL RINGS	0.020639574	0.7730672522761984
GAUCHER DISEASE	0.020611849999999998	0.7720288337263723
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.7678102115482273
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443213999999998	0.7657124742339309
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.020369364	0.7629463795179936
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020150623	0.7547533080994582
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.020088734	0.7524352195974318
FG SYNDROME TYPE 1	0.020016633	0.7497346346940629
BAND HETEROTOPIA; BH	0.019954873	0.7474213779620889
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7474213779620889
CORNELIA DE LANGE SYNDROME	0.019734099	0.7391521593457537
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.019704194	0.7380320501720218
16P13.2 MICRODELETION SYNDROME	0.019677793	0.7370431853569173
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7269873354887175
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7269873354887175
HHHH SYNDROME	0.019409319	0.7269873354887175
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.7225398971613556
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.019275884	0.7219894499312213
OKAMOTO SYNDROME	0.019270363999999998	0.7217826951196846
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.7193734022759751
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.714731307289998
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.018933593999999998	0.7091687788368652
NON-DISTAL MONOSOMY 20Q	0.018932908999999998	0.7091431217633322
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.018910813	0.7083155032278773
TOE, MISSHAPEN	0.0188679	0.7067081718460896
TRACHEOBRONCHOMEGALY	0.0188679	0.7067081718460896
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7067081718460896
MONOPHALANGY OF GREAT TOE	0.0188679	0.7067081718460896
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7067081718460896
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7067081718460896
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7067081718460896
RAYNAUD DISEASE	0.0188679	0.7067081718460896
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7067081718460896
THROMBOCYTOPENIA 3	0.0188679	0.7067081718460896
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7067081718460896
CARPAL DISPLACEMENT	0.0188679	0.7067081718460896
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7067081718460896
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7067081718460896
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7067081718460896
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.7067081718460896
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7067081718460896
KNUCKLE PADS	0.0188679	0.7067081718460896
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7067081718460896
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7067081718460896
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7067081718460896
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7067081718460896
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7067081718460896
LETTERER-SIWE DISEASE	0.0188679	0.7067081718460896
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7067081718460896
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7067081718460896
SPINAL ARACHNOIDITIS	0.0188679	0.7067081718460896
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7067081718460896
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7067081718460896
VAN DEN BOSCH SYNDROME	0.0188679	0.7067081718460896
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7067081718460896
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7067081718460896
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7067081718460896
VESICOURETERAL REFLUX 1	0.0188679	0.7067081718460896
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7067081718460896
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7067081718460896
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7067081718460896
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7067081718460896
NEPHROSIALIDOSIS	0.0188679	0.7067081718460896
PUBIC BONE DYSPLASIA	0.0188679	0.7067081718460896
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7067081718460896
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01859082	0.6963299792409182
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6942972648166268
AL KAISSI SYNDROME; ALKAS	0.018196433	0.6815579847015226
EMANUEL SYNDROME	0.018185983	0.6811665738717114
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018008939999999998	0.6745353253030764
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.017981514	0.673508068516627
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.017954909999999998	0.672511600218417
6Q25 MICRODELETION SYNDROME	0.017934033	0.6717296400371765
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.017644564	0.6608874102290836
PEDIATRIC-ONSET GRAVES DISEASE	0.017644564	0.6608874102290836
RUBINSTEIN-TAYBI SYNDROME	0.017521433000000003	0.6562754669864557
1P36 DELETION SYNDROME	0.017521433	0.6562754669864556
SAETHRE-CHOTZEN SYNDROME	0.017473019	0.6544620924491855
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.017365939	0.650451348750031
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.017309632999999998	0.6483423747611946
CRANIOFRONTONASAL DYSPLASIA	0.01726492	0.6466676233321668
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6457866680482285
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6457866680482285
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6457866680482285
ERYTHERMALGIA, PRIMARY	0.0172414	0.6457866680482285
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6457866680482285
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6457866680482285
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6457866680482285
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6457866680482285
CARDIAC ARRHYTHMIA	0.0172414	0.6457866680482285
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6457866680482285
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6457866680482285
MOSAIC TRISOMY 15	0.0172414	0.6457866680482285
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6457866680482285
CERVICAL RIB	0.0172414	0.6457866680482285
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6457866680482285
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6457866680482285
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6457866680482285
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6457866680482285
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6457866680482285
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6457866680482285
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6457866680482285
TRANSSEXUALITY	0.0172414	0.6457866680482285
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6457866680482285
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6457866680482285
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6457866680482285
SICKLE CELL ANEMIA	0.0172414	0.6457866680482285
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6457866680482285
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6457866680482285
PALMOMENTAL REFLEX	0.0172414	0.6457866680482285
ALCOHOL DEPENDENCE	0.0172414	0.6457866680482285
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6457866680482285
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6457866680482285
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6457866680482285
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6457866680482285
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6457866680482285
DIASTEMATOMYELIA	0.0172414	0.6457866680482285
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6457866680482285
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6457866680482285
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6457866680482285
MOTION SICKNESS	0.0172414	0.6457866680482285
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6457866680482285
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6457866680482285
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6457866680482285
RHEUMATOID ARTHRITIS	0.0172414	0.6457866680482285
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6457866680482285
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6457866680482285
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6457866680482285
269800 SENILE PLAQUE FORMATION	0.0172414	0.6457866680482285
MYOPATHY, CONGENITAL	0.0172414	0.6457866680482285
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6457866680482285
DESMOSTEROLOSIS	0.01719066	0.6438861718276914
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.6405756227747078
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.017099009999999998	0.6404533677557123
CONGENITAL ANALBUMINEMIA	0.017099009999999998	0.6404533677557123
INDOMETHACIN EMBRYOFETOPATHY	0.017099009999999998	0.6404533677557123
RENAL TUBULAR DYSGENESIS	0.017099009999999998	0.6404533677557123
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.016931599999999998	0.6341829288065577
SUMMITT SYNDROME	0.016931599999999998	0.6341829288065577
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.016931599999999998	0.6341829288065577
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.016898068999999998	0.6329270056932185
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016891613	0.6326851924571172
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6310165837435047
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6310165837435047
RING CHROMOSOME 7 SYNDROME	0.016847059999999997	0.6310164339211772
CUTIS LAXA	0.016768214	0.6280632111185668
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.016764078999999998	0.6279083322878233
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.016716994	0.6261447362187657
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.016555979999999998	0.6201138631708044
CORNELIA DE LANGE SYNDROME 3	0.016387253	0.6137940952204193
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.016350194	0.6124060288144894
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016350194	0.6124060288144894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.016350194	0.6124060288144894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016350194	0.6124060288144894
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6105825412701332
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6105825412701332
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6105825412701332
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6105825412701332
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6105825412701332
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.6102763044333357
NEUROFACIODIGITORENAL SYNDROME	0.01622266	0.6076291686451956
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.016125574	0.6039927560305511
3MC SYNDROME 2	0.016023693999999998	0.6001767813567569
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.015969393	0.5981429058094297
AICARDI-GOUTIÈRES SYNDROME	0.015923613	0.5964281892746213
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.015845834	0.5935149315777913
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.015845834	0.5935149315777913
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01580464	0.591971986341118
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01580464	0.591971986341118
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.591971986341118
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01580464	0.591971986341118
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.0157379	0.5894722008117794
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.015678313	0.5872403350590569
6Q TERMINAL DELETION SYNDROME	0.015678313	0.5872403350590569
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01566324	0.586675767074584
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01566324	0.586675767074584
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.015635813999999998	0.5856485102881345
PERLMAN SYNDROME	0.015635813999999998	0.5856485102881345
DUANE RETRACTION SYNDROME	0.015627092999999998	0.5853218601592558
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.015557828999999999	0.5827275367414538
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5794735830725701
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5794735830725701
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5794735830725701
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5794735830725701
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5794735830725701
MUCOPOLYSACCHARIDOSIS TYPE 2	0.015426473	0.57780752133852
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.015423838999999998	0.5777088633360585
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.015378059	0.5759941468012499
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.015293772999999998	0.5728371656336468
SILVER-RUSSELL SYNDROME	0.0151932	0.5690701454052655
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.015181173000000001	0.5686196671229558
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.015181173000000001	0.5686196671229558
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.015178728999999998	0.5685281256810363
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.015136893999999998	0.5669611714164291
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.015135473	0.5669079470346912
MALAN OVERGROWTH SYNDROME	0.015132758999999999	0.5668062925856857
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01510677	0.565832859470283
TETRASOMY X	0.015015374000000001	0.5624095691160812
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5590395405991989
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5590395405991989
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5590395405991989
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5590395405991989
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.014808660000000001	0.5546669759798555
PFEIFFER SYNDROME	0.01480314	0.5544602211683188
COFFIN-SIRIS SYNDROME 6; CSS6	0.014752353999999999	0.5525580019910189
VELO-FACIAL-SKELETAL SYNDROME	0.014724120000000002	0.5515004810944751
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.01472412	0.551500481094475
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.014667814	0.5493915071056386
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.014656572999999999	0.5489704689106237
SPINOCEREBELLAR ATAXIA TYPE 13	0.014600473	0.5468692107716382
FAMILIAL LAMBDOID SYNOSTOSIS	0.014591339999999998	0.5465271289430578
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.014591339999999998	0.5465271289430578
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.014591339999999998	0.5465271289430578
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.014591339999999998	0.5465271289430578
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.014591339999999998	0.5465271289430578
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.014392009999999998	0.539061107822844
HAMAMY SYNDROME; HMMS	0.014339500000000002	0.5370943152225209
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5335230753202086
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5335230753202086
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5335230753202086
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5335230753202086
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5335230753202086
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5335230753202086
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014240018999999998	0.5333681964894652
TRISOMY 20P	0.014206799999999999	0.5321239595176477
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.014059054	0.5265900471290103
ZEBRA BODY MYOPATHY	0.014059054	0.5265900471290103
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.014059054	0.5265900471290103
OGDEN SYNDROME	0.014059054	0.5265900471290103
CITRULLINEMIA TYPE I	0.014054918999999999	0.5264351682982669
KUFOR-RAKEB SYNDROME	0.014054918999999999	0.5264351682982669
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.014054918999999999	0.5264351682982669
RAPID-ONSET DYSTONIA-PARKINSONISM	0.014054918999999999	0.5264351682982669
QAZI-MARKOUIZOS SYNDROME	0.014054918999999999	0.5264351682982669
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014004494	0.5245464705859969
ROBERTS SYNDROME	0.013722894000000001	0.513998978751089
ROIFMAN SYNDROME; RFMN	0.013722894000000001	0.513998978751089
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.5130890328468373
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5130890328468373
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5130890328468373
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5130890328468373
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5130890328468373
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5130890328468373
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5130890328468373
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5130890328468373
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5130890328468373
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.013671174	0.5120617760603878
RING CHROMOSOME 14 SYNDROME	0.013671174	0.5120617760603878
WRINKLY SKIN SYNDROME	0.013671174	0.5120617760603878
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671174	0.5120617760603878
PEHO-LIKE SYNDROME; PEHOL	0.013671174	0.5120617760603878
MUENKE SYNDROME	0.013662452999999998	0.5117351259315092
FANCONI ANEMIA	0.013597324	0.5092956813444506
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.013577912999999999	0.5085686310461288
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.013577912999999999	0.5085686310461288
CARNOSINASE DEFICIENCY	0.013569600000000001	0.5082572627946247
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.013555372999999999	0.5077243822323546
SPASMUS NUTANS	0.0135135	0.506156004655639
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.0135135	0.506156004655639
BETHLEM MYOPATHY	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT17 TYPE	0.0135135	0.506156004655639
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0135135	0.506156004655639
DYSTONIA 26, MYOCLONIC; DYT26	0.0135135	0.506156004655639
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0135135	0.506156004655639
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0135135	0.506156004655639
OROMANDIBULAR DYSTONIA	0.0135135	0.506156004655639
DYSTONIA 11, MYOCLONIC	0.0135135	0.506156004655639
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0135135	0.506156004655639
SPINOCEREBELLAR ATAXIA TYPE 35	0.0135135	0.506156004655639
DYSTONIA 21; DYT21	0.0135135	0.506156004655639
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.0135135	0.506156004655639
MYOCLONUS-DYSTONIA SYNDROME	0.0135135	0.506156004655639
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.0135135	0.506156004655639
ACERULOPLASMINEMIA	0.0135135	0.506156004655639
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.0135135	0.506156004655639
FAMILIAL PAROXYSMAL ATAXIA	0.0135135	0.506156004655639
SPRENGEL DEFORMITY	0.0135135	0.506156004655639
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.0135135	0.506156004655639
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.0135135	0.506156004655639
SANDIFER SYNDROME	0.0135135	0.506156004655639
DYSTONIA 16	0.0135135	0.506156004655639
DYSTONIA 7, TORSION	0.0135135	0.506156004655639
BETHLEM MYOPATHY 1	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT21 TYPE	0.0135135	0.506156004655639
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.0135135	0.506156004655639
AUTOSOMAL DOMINANT FOCAL DYSTONIA, DYT25 TYPE	0.0135135	0.506156004655639
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT4 TYPE	0.0135135	0.506156004655639
DYSTONIA 13, TORSION	0.0135135	0.506156004655639
TORTICOLLIS	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT2 TYPE	0.0135135	0.506156004655639
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0135135	0.506156004655639
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0135135	0.506156004655639
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0135135	0.506156004655639
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT6 TYPE	0.0135135	0.506156004655639
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0135135	0.506156004655639
DYSTONIA 12; DYT12	0.0135135	0.506156004655639
DYSTONIA 23; DYT23	0.0135135	0.506156004655639
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT13 TYPE	0.0135135	0.506156004655639
DYSTONIA 25	0.0135135	0.506156004655639
SPINOCEREBELLAR ATAXIA TYPE 17	0.0135135	0.506156004655639
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.0135135	0.506156004655639
ACERULOPLASMINEMIA	0.0135135	0.506156004655639
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0135135	0.506156004655639
TRISOMY X	0.013507613	0.5059355036455819
48,XXYY SYNDROME	0.013507613	0.5059355036455819
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.013507613	0.5059355036455819
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.013461833	0.5042207871107732
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.013384054000000001	0.5013075294139435
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.013379918999999999	0.5011526505832
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.013305034000000002	0.49834778934009966
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.013302109	0.49823823176333426
MIETENS SYNDROME	0.013299514000000002	0.4981410345285631
PELIZAEUS-MERZBACHER DISEASE	0.013255119	0.4964781939745476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.013244592999999999	0.49608393652051974
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.013244592999999999	0.49608393652051974
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.013244592999999999	0.49608393652051974
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.013244592999999999	0.49608393652051974
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.013216532999999999	0.495032932895209
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.013177340000000001	0.49356493627771775
RAINE SYNDROME	0.013121033999999998	0.49145596228888133
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.013121033999999998	0.49145596228888133
JACOBSEN SYNDROME	0.013086293	0.4901547179215642
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013032358999999999	0.4881345885727575
ACROCALLOSAL SYNDROME; ACLS	0.012976398999999998	0.486038574215224
MUCOPOLYSACCHARIDOSIS TYPE 3	0.012916279	0.483786744637402
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.012837163999999998	0.48082344628328716
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.012760689999999998	0.47795906812070643
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.012703174	0.47580477287789197
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.012670979	0.4745988904218378
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.47123890000087804
FIBROCHONDROGENESIS	0.012575479999999998	0.47102191981551006
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.012575479999999998	0.47102191981551006
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012540739	0.4697206754481929
ZELLWEGER SYNDROME	0.012540739	0.4697206754481929
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.012490939999999999	0.4678554249301297
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.4678554249301297
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.4678554249301297
TEMPLE SYNDROME	0.012468400000000001	0.4670111761163555
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.01242064	0.4652222975295828
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.012215133000000001	0.4575249132805898
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01215762	0.45537073040452064
FRANK-TER HAAR SYNDROME; FTHS	0.012129560000000001	0.45431972677920995
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.01207834	0.45240125187940883
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012039854	0.45095973635825026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45095973635825026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45095973635825026
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45095973635825026
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45095973635825026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45095973635825026
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45095973635825026
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45095973635825026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45095973635825026
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45095973635825026
FUMARASE DEFICIENCY; FMRD	0.012039854	0.45095973635825026
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.45095973635825026
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012039854	0.45095973635825026
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.45095973635825026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.45095973635825026
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45095973635825026
CLASSICAL EHLERS-DANLOS SYNDROME	0.01199932	0.449441511805565
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.011876293000000001	0.4448334639434443
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.011876293000000001	0.4448334639434443
ROIFMAN-CHITAYAT SYNDROME	0.011769454	0.44083174703950345
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.011652843999999999	0.4364640516457938
PELGER-HUET ANOMALY; PHA	0.011652843999999999	0.4364640516457938
W SYNDROME	0.011652843999999999	0.4364640516457938
KLEEFSTRA SYNDROME 2; KLEFS2	0.011613272999999999	0.4349818968183821
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.011613272999999999	0.4349818968183821
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.011613272999999999	0.4349818968183821
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.011613272999999999	0.4349818968183821
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.011613272999999999	0.4349818968183821
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.011613272999999999	0.4349818968183821
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.011613272999999999	0.4349818968183821
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.011511533000000001	0.4311711659260401
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4305256938848789
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4305256938848789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4305256938848789
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4305256938848789
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4305256938848789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4305256938848789
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4305256938848789
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.011472773	0.4297193875754683
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.011472773	0.4297193875754683
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011454973	0.42905267821942644
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.011420449999999999	0.4277595991689416
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.011420449999999999	0.4277595991689416
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.011413943	0.4275158756981684
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011413943	0.4275158756981684
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.011413943	0.4275158756981684
MELAS	0.01135259	0.42521786338798695
ARTERIAL TORTUOSITY SYNDROME	0.011334874000000002	0.4245543003008164
2Q23.1 MICRODELETION SYNDROME	0.011330739000000001	0.42439942147007303
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.011290383999999999	0.4228879014665299
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.011286248999999998	0.42273302263578655
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0112239	0.42039770456613224
COG5-CDG	0.011201708999999999	0.41956652775040615
TEMPLE SYNDROME	0.011128160000000002	0.41681170716459076
INFANTILE SIALIC ACID STORAGE DISEASE	0.011121653	0.4165679836938174
ISOLATED PLAGIOCEPHALY	0.011071853999999999	0.41470273317575423
CRANIOSYNOSTOSIS 6; CRS6	0.011071853999999999	0.41470273317575423
BRESEK SYNDROME	0.011071853999999999	0.41470273317575423
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.011071853999999999	0.41470273317575423
LINEAR NEVUS SEBACEUS SYNDROME	0.011067718999999998	0.4145478543450108
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.011067718999999998	0.4145478543450108
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011067718999999998	0.4145478543450108
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.011067718999999998	0.4145478543450108
CINCA SYNDROME	0.010998094	0.411940009462179
ADAMS-OLIVER SYNDROME	0.010993959	0.41178513063143557
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.010970114	0.4108920022834122
PALLISTER-KILLIAN SYNDROME	0.010927219	0.409285345102097
XQ12-Q13.3 DUPLICATION SYNDROME	0.01089058	0.4079130100405231
TRISOMY 18	0.010872523999999998	0.40723671205554046
DIAPHANOSPONDYLODYSOSTOSIS	0.010872523999999998	0.40723671205554046
20Q13.33 MICRODELETION SYNDROME	0.010868389	0.4070818332247971
HYPERTELORISM, TEEBI TYPE	0.01080366	0.4046573708704585
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.010789320000000002	0.40412025782744515
SECKEL SYNDROME	0.010789320000000002	0.40412025782744515
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.010782813	0.4038765343566719
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.010782813	0.4038765343566719
KOOLEN-DE VRIES SYNDROME; KDVS	0.010782813	0.4038765343566719
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.010782813	0.4038765343566719
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.010744829999999999	0.40245385899315866
CAMPOMELIA, CUMMING TYPE	0.010744829999999999	0.40245385899315866
DOWN SYNDROME	0.01071564	0.4013605305604138
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.01066029	0.3992873641077783
FREEMAN-SHELDON SYNDROME	0.01066029	0.3992873641077783
MECKEL SYNDROME 12; MKS12	0.01066029	0.3992873641077783
MARINESCO-SJÖGREN SYNDROME	0.010659254	0.3992485601250334
OCCIPITAL HORN SYNDROME	0.010659254	0.3992485601250334
THANATOPHORIC DYSPLASIA	0.010655119	0.39909368129429
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.010655119	0.39909368129429
WILLIAMS SYNDROME	0.010631100000000001	0.3981940356750335
COSTELLO SYNDROME; CSTLO	0.010580234	0.39628882005118965
CARDIOFACIOCUTANEOUS SYNDROME	0.010580234	0.39628882005118965
VASCULAR EHLERS-DANLOS SYNDROME	0.010580234	0.39628882005118965
HEREDITARY OROTIC ACIDURIA	0.010574714	0.39608206523965306
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.010574714	0.39608206523965306
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.010526299999999999	0.394268690702383
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.010526299999999999	0.394268690702383
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.010526299999999999	0.394268690702383
ROBINOW-SORAUF SYNDROME	0.010526299999999999	0.394268690702383
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.010526299999999999	0.394268690702383
ATELOSTEOGENESIS, TYPE I; AO1	0.01045254	0.39150596698880774
CORNEODERMATOOSSEOUS SYNDROME	0.01045254	0.39150596698880774
KNIEST-LIKE DYSPLASIA, LETHAL	0.01045254	0.39150596698880774
CORNEODERMATOOSSEOUS SYNDROME	0.01045254	0.39150596698880774
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.01045254	0.39150596698880774
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.010368	0.3883394721034274
RENAL AGENESIS, BILATERAL	0.01032697	0.3868026695821693
ACRORENAL-MANDIBULAR SYNDROME	0.01032697	0.3868026695821693
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.01032697	0.3868026695821693
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.0101137	0.3788145176516622
MULTIPLE EPIPHYSEAL DYSPLASIA	0.0101137	0.3788145176516622
GMS SYNDROME	0.01003468	0.3758547775778184
ACITRETIN/ETRETINATE EMBRYOPATHY	0.01003468	0.3758547775778184
DIAMOND-BLACKFAN ANEMIA 1	0.01003468	0.3758547775778184
PETERS-PLUS SYNDROME; PTRPLS	0.009925993000000001	0.371783842758711
FILIPPI SYNDROME	0.009841453	0.3686173478733306
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36724501281175675
KRABBE DISEASE	0.009804814	0.36724501281175675
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36724501281175675
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.36724501281175675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.36724501281175675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36724501281175675
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36724501281175675
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36724501281175675
BIOTINIDASE DEFICIENCY	0.009804814	0.36724501281175675
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36724501281175675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36724501281175675
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36724501281175675
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.36724501281175675
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36709013398101337
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36709013398101337
17Q12 MICRODELETION SYNDROME	0.009782622999999999	0.3664138359960307
ADAMS-OLIVER SYNDROME 2; AOS2	0.009782622999999999	0.3664138359960307
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.009782622999999999	0.3664138359960307
OLIVER SYNDROME	0.00976705	0.3658305402206578
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009710179999999999	0.36370044128368617
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009710179999999999	0.36370044128368617
CRANIOFACIOFRONTODIGITAL SYNDROME	0.009710179999999999	0.36370044128368617
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00969584	0.36316332824067277
MOSAIC MONOSOMY X	0.00969584	0.36316332824067277
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00969584	0.36316332824067277
TURNER SYNDROME	0.00969584	0.36316332824067277
MONOSOMY X	0.00969584	0.36316332824067277
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00969584	0.36316332824067277
OROFACIODIGITAL SYNDROME TYPE 2	0.009552444	0.35779234763286577
CONGENITAL TOXOPLASMOSIS	0.009490333	0.3554659439916798
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.009490333	0.3554659439916798
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.3554659439916798
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.3554659439916798
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.3554659439916798
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.3554659439916798
GALLOWAY-MOWAT SYNDROME	0.009490333	0.3554659439916798
KAGAMI-OGATA SYNDROME	0.009490333	0.3554659439916798
KAGAMI-OGATA SYNDROME	0.009490333	0.3554659439916798
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009462353	0.354417936812913
PETERS PLUS SYNDROME	0.009384574	0.35150467911608313
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.009300034	0.3483381842307028
8P INVERTED DUPLICATION/DELETION SYNDROME	0.009295899	0.34818330539995934
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.009295899	0.34818330539995934
GAUCHER DISEASE TYPE 3	0.00925926	0.3468109703383855
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3468109703383855
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3468109703383855
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3468109703383855
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3468109703383855
HYDROXYLYSINURIA	0.00925926	0.3468109703383855
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3468109703383855
GLYCINE ENCEPHALOPATHY	0.00925926	0.3468109703383855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3468109703383855
CARNOSINEMIA	0.00925926	0.3468109703383855
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3468109703383855
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3468109703383855
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3468109703383855
MERRF	0.00925926	0.3468109703383855
PAINE SYNDROME	0.00925926	0.3468109703383855
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3468109703383855
GAUCHER DISEASE TYPE 2	0.00925926	0.3468109703383855
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3468109703383855
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3468109703383855
OROFACIODIGITAL SYNDROME TYPE 4	0.009241204	0.3461346723534029
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.009241204	0.3461346723534029
MOSAIC TRISOMY 9	0.009241204	0.3461346723534029
EVEN-PLUS SYNDROME	0.009241204	0.3461346723534029
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.009241204	0.3461346723534029
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.009237068999999999	0.34597979352265945
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.009237068999999999	0.34597979352265945
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.009237068999999999	0.34597979352265945
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.009237068999999999	0.34597979352265945
HADDAD SYNDROME	0.009237068999999999	0.34597979352265945
1Q44 MICRODELETION SYNDROME	0.009219124	0.34530765310725675
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.009151493	0.34277449465453425
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.009151493	0.34277449465453425
1Q21.1 MICRODUPLICATION SYNDROME	0.009151493	0.34277449465453425
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009151493	0.34277449465453425
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.009151493	0.34277449465453425
PRADER-WILLI SYNDROME; PWS	0.009151493	0.34277449465453425
TYSHCHENKO SYNDROME	0.008948914	0.33518678034905197
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.33518678034905197
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.33518678034905197
MICROFORM HOLOPROSENCEPHALY	0.008944779	0.33503190151830853
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.33503190151830853
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.33503190151830853
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.008916799	0.3339838943395418
DYSOSTEOSCLEROSIS	0.008916799	0.3339838943395418
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.008916799	0.3339838943395418
OROFACIODIGITAL SYNDROME TYPE 1	0.008911358999999999	0.33378013597454914
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.008832513	0.33082691317193863
SIALURIA	0.008747973	0.3276604182865582
SERKAL SYNDROME	0.00869565	0.3257006298800316
STÜVE-WIEDEMANN SYNDROME	0.00869565	0.3257006298800316
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00869565	0.3257006298800316
TRANSALDOLASE DEFICIENCY	0.00869565	0.3257006298800316
MECKEL SYNDROME, TYPE 1; MKS1	0.00869565	0.3257006298800316
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00869565	0.3257006298800316
HOLZGREVE SYNDROME	0.00869565	0.3257006298800316
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.00869565	0.3257006298800316
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00869565	0.3257006298800316
TERMINAL TRANSVERSE LIMB DEFECT	0.00869565	0.3257006298800316
POSTERIOR URETHRAL VALVE	0.00869565	0.3257006298800316
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00869565	0.3257006298800316
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.00869565	0.3257006298800316
RENAL AGENESIS	0.00869565	0.3257006298800316
THOMAS SYNDROME	0.00869565	0.3257006298800316
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00869565	0.3257006298800316
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00869565	0.3257006298800316
MECKEL SYNDROME	0.00869565	0.3257006298800316
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00869565	0.3257006298800316
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800316
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00869565	0.3257006298800316
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.00869565	0.3257006298800316
ULBRIGHT-HODES SYNDROME	0.00869565	0.3257006298800316
HEMOCHROMATOSIS, NEONATAL	0.00869565	0.3257006298800316
HB BART'S HYDROPS FETALIS	0.00869565	0.3257006298800316
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00869565	0.3257006298800316
FONTAINE PROGEROID SYNDROME; FPS	0.00869565	0.3257006298800316
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800316
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00869565	0.3257006298800316
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00869565	0.3257006298800316
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800316
ACRO-RENAL-MANDIBULAR SYNDROME	0.00869565	0.3257006298800316
PRUNE BELLY SYNDROME	0.00869565	0.3257006298800316
46,XX DISORDER OF SEX DEVELOPMENT-ANORECTAL ANOMALIES SYNDROME	0.00869565	0.3257006298800316
ALPHA-MANNOSIDOSIS	0.008610074	0.3224953310119064
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.008610074	0.3224953310119064
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.008610074	0.3224953310119064
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.008610074	0.3224953310119064
AU-KLINE SYNDROME; AUKS	0.008610074	0.3224953310119064
PRADER-WILLI SYNDROME	0.008605939	0.322340452181163
16Q24.3 MICRODELETION SYNDROME	0.008605939	0.322340452181163
SECKEL SYNDROME 7; SCKL7	0.008605939	0.322340452181163
9Q21.13 MICRODELETION SYNDROME	0.008605939	0.322340452181163
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3147527378756807
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.3147527378756807
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.3147527378756807
HYDROLETHALUS	0.00840336	0.3147527378756807
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.3147527378756807
BECKWITH-WIEDEMANN SYNDROME	0.00840336	0.3147527378756807
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3147527378756807
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.3147527378756807
OMPHALOCELE	0.00840336	0.3147527378756807
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.3147527378756807
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.3147527378756807
SCHISIS ASSOCIATION	0.00840336	0.3147527378756807
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.3147527378756807
FATCO SYNDROME	0.00840336	0.3147527378756807
HEC SYNDROME	0.00840336	0.3147527378756807
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.3147527378756807
RETINOPATHY OF PREMATURITY	0.00840336	0.3147527378756807
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.3147527378756807
PEMPHIGOID GESTATIONIS	0.00840336	0.3147527378756807
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3147527378756807
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.3147527378756807
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3147527378756807
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3147527378756807
VACTERL/VATER ASSOCIATION	0.00840336	0.3147527378756807
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.3147527378756807
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.3147527378756807
YUNIS-VARON SYNDROME	0.00840336	0.3147527378756807
NEMALINE MYOPATHY 10	0.00840336	0.3147527378756807
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.3147527378756807
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3147527378756807
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.3147527378756807
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.3147527378756807
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.3147527378756807
DISTAL MONOSOMY 17Q	0.00840336	0.3147527378756807
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.3147527378756807
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3147527378756807
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3147527378756807
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.3147527378756807
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.3147527378756807
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.3147527378756807
EBSTEIN MALFORMATION	0.00840336	0.3147527378756807
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.3147527378756807
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3147527378756807
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.3147527378756807
MONOSOMY 13Q14	0.00836994	0.3135009723319213
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00836994	0.3135009723319213
NON-DISTAL MONOSOMY 10Q	0.00836994	0.3135009723319213
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.008291093999999999	0.3105477495293107
OGDEN SYNDROME; OGDNS	0.008206554	0.30738125464393035
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.008206554	0.30738125464393035
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.008206554	0.30738125464393035
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008206554	0.30738125464393035
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.008206554	0.30738125464393035
OPITZ G/BBB SYNDROME	0.008206554	0.30738125464393035
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.008202419	0.307226375813187
SHORT SYNDROME	0.00807886	0.30259840158154855
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00806452	0.30206128853853514
CRANIOECTODERMAL DYSPLASIA 4	0.00806452	0.30206128853853514
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00806452	0.30206128853853514
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00806452	0.30206128853853514
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.30206128853853514
FEMORAL-FACIAL SYNDROME	0.00806452	0.30206128853853514
13Q12.3 MICRODELETION SYNDROME	0.00806452	0.30206128853853514
CLASSIC MULTIMINICORE MYOPATHY	0.00806452	0.30206128853853514
CAT-EYE SYNDROME	0.00806452	0.30206128853853514
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00806452	0.30206128853853514
TIBIAL HEMIMELIA	0.00806452	0.30206128853853514
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00806452	0.30206128853853514
COXOPODOPATELLAR SYNDROME	0.00806452	0.30206128853853514
DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2	0.00806452	0.30206128853853514
SCHWARTZ-JAMPEL SYNDROME	0.00806452	0.30206128853853514
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00806452	0.30206128853853514
DIASTROPHIC DWARFISM	0.00806452	0.30206128853853514
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00806452	0.30206128853853514
SPONASTRIME DYSPLASIA	0.00806452	0.30206128853853514
MEIER-GORLIN SYNDROME 6; MGORS6	0.00806452	0.30206128853853514
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00806452	0.30206128853853514
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00806452	0.30206128853853514
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00806452	0.30206128853853514
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00806452	0.30206128853853514
BRITTLE CORNEA SYNDROME	0.00806452	0.30206128853853514
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00806452	0.30206128853853514
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00806452	0.30206128853853514
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00806452	0.30206128853853514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00806452	0.30206128853853514
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.30206128853853514
ATYPICAL WERNER SYNDROME	0.00806452	0.30206128853853514
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00806452	0.30206128853853514
SMITH-MAGENIS SYNDROME	0.007825593	0.29311213874578285
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.007825593	0.29311213874578285
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.007660999999999999	0.2869472121705591
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007660999999999999	0.2869472121705591
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.007660999999999999	0.2869472121705591
CARTILAGE-HAIR HYPOPLASIA	0.007660999999999999	0.2869472121705591
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.2842056134051191
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.2842056134051191
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.2842056134051191
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2842056134051191
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2842056134051191
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.2842056134051191
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2842056134051191
SARCOSINEMIA	0.007587804	0.2842056134051191
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28405073457437563
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28405073457437563
ATYPICAL RETT SYNDROME	0.007576559	0.28378442538777693
RETT SYNDROME	0.007576559	0.28378442538777693
2Q31.1 MICRODELETION SYNDROME	0.007492273000000001	0.2806274442201738
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007492273000000001	0.2806274442201738
TETRASOMY 5P	0.007407733	0.2774609493347934
MONOSOMY 22Q13.3	0.007407733	0.2774609493347934
MAN1B1-CDG	0.007407733	0.2774609493347934
PHELAN-MCDERMID SYNDROME	0.007407733	0.2774609493347934
SIMPSON-GOLABI-BEHMEL SYNDROME	0.007407733	0.2774609493347934
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007407733	0.2774609493347934
20Q11.2 MICRODUPLICATION SYNDROME	0.007407733	0.2774609493347934
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.007407733	0.2774609493347934
1Q21.1 MICRODELETION SYNDROME	0.007407733	0.2774609493347934
ZTTK SYNDROME; ZTTKS	0.007361953	0.2757462327999849
LARSEN-LIKE SYNDROME	0.007335394	0.2747514500029561
CRANIOFRONTONASAL SYNDROME; CFNS	0.007284174000000001	0.272832975103155
FLOATING-HARBOR SYNDROME	0.007284174000000001	0.272832975103155
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007201193	0.26972487346980095
GRACILE BONE DYSPLASIA; GCLEB	0.007201193	0.26972487346980095
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0071166530000000006	0.2665583785844206
BOHRING-OPITZ SYNDROME	0.0071166530000000006	0.2665583785844206
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0071166530000000006	0.2665583785844206
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0071166530000000006	0.2665583785844206
HEART AND BRAIN MALFORMATION SYNDROME	0.0071166530000000006	0.2665583785844206
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0071166530000000006	0.2665583785844206
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.2637715709317478
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.2637715709317478
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.2637715709317478
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.2637715709317478
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.2637715709317478
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.2637715709317478
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.2637715709317478
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.2637715709317478
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.2637715709317478
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.2637715709317478
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.2637715709317478
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.2637715709317478
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.2637715709317478
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.2637715709317478
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.2637715709317478
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.2637715709317478
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.2637715709317478
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.2637715709317478
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.2637715709317478
AMISH LETHAL MICROCEPHALY	0.00704225	0.2637715709317478
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.2637715709317478
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.2637715709317478
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.2637715709317478
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.2637715709317478
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.2637715709317478
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.2637715709317478
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.007028633000000001	0.26326153827437593
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.007028633	0.2632615382743759
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.007028633	0.2632615382743759
RING CHROMOSOME 22 SYNDROME	0.007028633	0.2632615382743759
CHARGE SYNDROME	0.006950854	0.26034828057754594
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0069467190000000005	0.26019340174680256
DUBOWITZ SYNDROME	0.0069467190000000005	0.26019340174680256
DUPLICATION/INVERSION 15Q11	0.0069467190000000005	0.26019340174680256
OCULODENTODIGITAL DYSPLASIA	0.0069467190000000005	0.26019340174680256
TRISOMY 12P	0.006866314	0.25718178569216554
LIG4 SYNDROME	0.006866314	0.25718178569216554
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.006862179000000001	0.25702690686142227
RENPENNING SYNDROME 1; RENS1	0.0068621789999999995	0.25702690686142216
WIEDEMANN-STEINER SYNDROME	0.0068621789999999995	0.25702690686142216
OHDO SYNDROME	0.0068621789999999995	0.25702690686142216
NEONATAL ADRENOLEUKODYSTROPHY	0.006816399000000001	0.2553121903266137
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00678984	0.2543174075295848
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00678984	0.2543174075295848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006783333000000001	0.2540736840588116
DISTAL MONOSOMY 1Q	0.006783333000000001	0.2540736840588116
PMM2-CDG	0.006783332999999999	0.25407368405881153
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.006783332999999999	0.25407368405881153
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.006783332999999999	0.25407368405881153
19P13.13 MICRODELETION SYNDROME	0.006783332999999999	0.25407368405881153
FRANK-TER HAAR SYNDROME	0.006738620000000001	0.25239893262978375
MATERNAL PHENYLKETONURIA	0.006732113	0.25215520915901046
SMITH-LEMLI-OPITZ SYNDROME	0.006732113	0.25215520915901046
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.006732113	0.25215520915901046
COFFIN-SIRIS SYNDROME 7; CSS7	0.006659774	0.24944570982717312
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006659774	0.24944570982717312
20P13 MICRODELETION SYNDROME	0.006655639	0.2492908309964297
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.006575234	0.24627921494179272
STEEL SYNDROME; STLS	0.006575234	0.24627921494179272
SYNDROMIC DIARRHEA	0.006575234	0.24627921494179272
ZECHI-CEIDE SYNDROME	0.006575234	0.24627921494179272
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.006571099	0.24612433611104936
14Q12 MICRODELETION SYNDROME	0.006483079	0.2428274958010046
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0064053	0.23991423810417473
JACOBSEN SYNDROME	0.0064053	0.23991423810417473
URBAN-ROGERS-MEYER SYNDROME	0.0064053	0.23991423810417473
CRANIOECTODERMAL DYSPLASIA	0.0064053	0.23991423810417473
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.0064053	0.23991423810417473
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.0064053	0.23991423810417473
MOEBIUS SYNDROME	0.0064053	0.23991423810417473
9P13 MICRODELETION SYNDROME	0.00632076	0.23674774321879433
CRANIOFACIAL DYSSYNOSTOSIS	0.00632076	0.23674774321879433
DUBOWITZ SYNDROME	0.00632076	0.23674774321879433
DE BARSY SYNDROME	0.0062419139999999994	0.23379452041618368
NOONAN SYNDROME 5; NS5	0.0062419139999999994	0.23379452041618368
FETAL TRIMETHADIONE SYNDROME	0.0062419139999999994	0.23379452041618368
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0062419139999999994	0.23379452041618368
JOUBERT SYNDROME 1	0.0062419139999999994	0.23379452041618368
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0062419139999999994	0.23379452041618368
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.006237778999999999	0.23363964158544026
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.006237778999999999	0.23363964158544026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.006237778999999999	0.23363964158544026
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.006237778999999999	0.23363964158544026
DISTAL MONOSOMY 9P	0.006190694	0.23187604551638263
MONOSOMY 18P	0.006190694	0.23187604551638263
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.006190694	0.23187604551638263
HALL-RIGGS SYNDROME	0.0061865589999999995	0.23172116668563922
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0061865589999999995	0.23172116668563922
OROFACIODIGITAL SYNDROME I; OFD1	0.0061865589999999995	0.23172116668563922
POTOCKI-SHAFFER SYNDROME	0.0061865589999999995	0.23172116668563922
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00611422	0.22901166735380188
ODONTOCHONDRODYSPLASIA; ODCD	0.00611422	0.22901166735380188
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00611422	0.22901166735380188
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00611422	0.22901166735380188
LARSEN SYNDROME	0.00611422	0.22901166735380188
KEIPERT SYNDROME; KPTS	0.00611422	0.22901166735380188
HYPERTELORISM, TEEBI TYPE; TBHS	0.00602968	0.22584517246842148
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00602968	0.22584517246842148
SHORT SYNDROME	0.00602968	0.22584517246842148
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00602968	0.22584517246842148
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00602968	0.22584517246842148
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00602968	0.22584517246842148
ZECHI-CEIDE SYNDROME	0.00602968	0.22584517246842148
TEEBI-SHALTOUT SYNDROME; TBSH	0.00602968	0.22584517246842148
AXENFELD-RIEGER SYNDROME	0.00602968	0.22584517246842148
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.005860953	0.21952540451803618
RUVALCABA SYNDROME	0.005860953	0.21952540451803618
2Q37 MICRODELETION SYNDROME	0.005860953	0.21952540451803618
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.005776413000000001	0.21635890963265583
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005696359999999999	0.21336047794281243
NASODIGITOACOUSTIC SYNDROME	0.005696359999999999	0.21336047794281243
CEREBROOCULONASAL SYNDROME	0.005696359999999999	0.21336047794281243
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.005696359999999999	0.21336047794281243
CEREBROOCULONASAL SYNDROME	0.005696359999999999	0.21336047794281243
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.005696359999999999	0.21336047794281243
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.005696359999999999	0.21336047794281243
FRONTONASAL DYSPLASIA 1; FND1	0.00564514	0.2114420030430114
ACRODYSOSTOSIS	0.00564514	0.2114420030430114
GORLIN SYNDROME	0.00564514	0.2114420030430114
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00564514	0.2114420030430114
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00564514	0.2114420030430114
CRANIOECTODERMAL DYSPLASIA 1	0.00564514	0.2114420030430114
15Q11Q13 MICRODUPLICATION SYNDROME	0.005443093	0.20387421510704679
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0054430929999999995	0.20387421510704673
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0054430929999999995	0.20387421510704673
48,XXXY SYNDROME	0.0054430929999999995	0.20387421510704673
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0054430929999999995	0.20387421510704673
49,XXXXY SYNDROME	0.0054430929999999995	0.20387421510704673
19P13.12 MICRODELETION SYNDROME	0.0054430929999999995	0.20387421510704673
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0054430929999999995	0.20387421510704673
TETRASOMY 9P	0.0054430929999999995	0.20387421510704673
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005397313000000001	0.20215949857223825
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005397313000000001	0.20215949857223825
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005397313000000001	0.20215949857223825
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.005397313000000001	0.20215949857223825
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.005397313000000001	0.20215949857223825
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005397313000000001	0.20215949857223825
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.005397313000000001	0.20215949857223825
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.005397313000000001	0.20215949857223825
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005397313000000001	0.20215949857223825
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.005397313000000001	0.20215949857223825
NIEMANN-PICK DISEASE TYPE C	0.005397313000000001	0.20215949857223825
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.005397313000000001	0.20215949857223825
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005397313000000001	0.20215949857223825
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.005397313000000001	0.20215949857223825
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.005397313000000001	0.20215949857223825
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.005397313000000001	0.20215949857223825
MULTIPLE SULFATASE DEFICIENCY	0.005397313	0.2021594985722382
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005397313	0.2021594985722382
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005397313	0.2021594985722382
HSD10 DISEASE	0.005397313	0.2021594985722382
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.005397313	0.2021594985722382
OPTIC PATHWAY GLIOMA	0.005397313	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.005397313	0.2021594985722382
CHÉDIAK-HIGASHI SYNDROME	0.005397313	0.2021594985722382
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.005397313	0.2021594985722382
AICARDI-GOUTIERES SYNDROME 7	0.005397313	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.005397313	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.005397313	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.005397313	0.2021594985722382
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.005397313	0.2021594985722382
KLEEFSTRA SYNDROME	0.005397313	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.005397313	0.2021594985722382
CANAVAN DISEASE	0.005397313	0.2021594985722382
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.005397313	0.2021594985722382
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.005397313	0.2021594985722382
SCHINDLER DISEASE, TYPE I	0.005397313	0.2021594985722382
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005397313	0.2021594985722382
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.005397313	0.2021594985722382
TAY-SACHS DISEASE	0.005397313	0.2021594985722382
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005397313	0.2021594985722382
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.005397313	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005397313	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.005397313	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005397313	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005397313	0.2021594985722382
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005397313	0.2021594985722382
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.005397313	0.2021594985722382
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.005397313	0.2021594985722382
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.005319534000000001	0.19924624087540835
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.005319534000000001	0.19924624087540835
%300712 CRANIOFACIOSKELETAL SYNDROME	0.005319534000000001	0.19924624087540835
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.005319534000000001	0.19924624087540835
TRISOMY 9P	0.005319534000000001	0.19924624087540835
TEMTAMY SYNDROME	0.005319534000000001	0.19924624087540835
TRISOMY 8P	0.005315399	0.19909136204466488
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.005315399	0.19909136204466488
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.005315399	0.19909136204466488
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.005234994000000001	0.19607974599002795
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.005230859000000001	0.1959248671592846
15Q OVERGROWTH SYNDROME	0.005230859000000001	0.1959248671592846
INTELLECTUAL DISABILITY, WOLFF TYPE	0.005230859000000001	0.1959248671592846
FRYNS SYNDROME	0.005230859000000001	0.1959248671592846
HENNEKAM-BEEMER SYNDROME	0.005230859000000001	0.1959248671592846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.005152013	0.19297164435667394
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.005152013	0.19297164435667394
PETTIGREW SYNDROME	0.005152013	0.19297164435667394
DESANTO-SHINAWI SYNDROME	0.005152013	0.19297164435667394
FUCOSIDOSIS	0.005152013	0.19297164435667394
WEBB-DATTANI SYNDROME; WEDAS	0.005152013	0.19297164435667394
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.005152013	0.19297164435667394
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005152013	0.19297164435667394
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.005152013	0.19297164435667394
SOTOS SYNDROME	0.005152013	0.19297164435667394
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005152013	0.19297164435667394
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005152013	0.19297164435667394
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.005152013	0.19297164435667394
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.005152013	0.19297164435667394
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.005152013	0.19297164435667394
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.005152013	0.19297164435667394
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.005152013	0.19297164435667394
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.005152013	0.19297164435667394
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.005152013	0.19297164435667394
SMITH-MAGENIS SYNDROME; SMS	0.005100792999999999	0.1910531694568728
DISTAL MONOSOMY 6P	0.004901674	0.1835950514644189
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004901674	0.1835950514644189
14Q22Q23 MICRODELETION SYNDROME	0.004901674	0.1835950514644189
17Q21.31 MICRODUPLICATION SYNDROME	0.004901674	0.1835950514644189
6Q16 MICRODELETION SYNDROME	0.004901674	0.1835950514644189
MILLER-DIEKER SYNDROME	0.004897539	0.1834401726336755
DISTAL MONOSOMY 3P	0.004897538999999999	0.18344017263367546
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004897538999999999	0.18344017263367546
RENPENNING SYNDROME	0.004897538999999999	0.18344017263367546
C SYNDROME	0.004897538999999999	0.18344017263367546
HYPERMANGANESEMIA WITH DYSTONIA 2	0.004855894	0.1818803349296104
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004855894	0.1818803349296104
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.004855894	0.1818803349296104
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004855894	0.1818803349296104
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.1818803349296104
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.004855894	0.1818803349296104
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.004855894	0.1818803349296104
AICARDI-GOUTIERES SYNDROME 6	0.004855894	0.1818803349296104
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004855894	0.1818803349296104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.1818803349296104
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004855894	0.1818803349296104
FLYNN-AIRD SYNDROME	0.004851759000000001	0.181725456098867
CADASIL	0.004851759000000001	0.181725456098867
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.004851759000000001	0.181725456098867
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004851759000000001	0.181725456098867
NORRIE DISEASE	0.004851759000000001	0.181725456098867
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.181725456098867
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004851759000000001	0.181725456098867
LYNCH SYNDROME	0.004851759000000001	0.181725456098867
CHOREOACANTHOCYTOSIS	0.004851759000000001	0.181725456098867
NASU-HAKOLA DISEASE	0.004851759000000001	0.181725456098867
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004851759000000001	0.181725456098867
MENKES DISEASE	0.004851759000000001	0.181725456098867
ALEXANDER DISEASE	0.004851759000000001	0.181725456098867
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.181725456098867
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.004851759000000001	0.181725456098867
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.004851759000000001	0.181725456098867
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.004851759000000001	0.181725456098867
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.004851759000000001	0.181725456098867
BEHÇET DISEASE	0.004851759000000001	0.181725456098867
SNEDDON SYNDROME	0.004851759000000001	0.181725456098867
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.004851759000000001	0.181725456098867
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.004851759000000001	0.181725456098867
NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.181725456098867
DILATED CARDIOMYOPATHY WITH ATAXIA	0.004851759000000001	0.181725456098867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.004851759000000001	0.181725456098867
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004851759000000001	0.181725456098867
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.181725456098867
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004851759000000001	0.181725456098867
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.181725456098867
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.004851759000000001	0.181725456098867
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.181725456098867
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.181725456098867
METACHROMATIC LEUKODYSTROPHY	0.004851759000000001	0.181725456098867
ETHYLMALONIC ENCEPHALOPATHY	0.004851759000000001	0.181725456098867
ADIPOSIS DOLOROSA	0.004851759000000001	0.181725456098867
TRIPLE A SYNDROME	0.004851759000000001	0.181725456098867
RETT SYNDROME, CONGENITAL VARIANT	0.004851759000000001	0.181725456098867
FAMILIAL COLORECTAL CANCER TYPE X	0.004851759000000001	0.181725456098867
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.181725456098867
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004851759000000001	0.181725456098867
KRABBE DISEASE	0.004851759000000001	0.181725456098867
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.004851759000000001	0.181725456098867
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.004851759000000001	0.181725456098867
ALEXANDER DISEASE	0.004851759000000001	0.181725456098867
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.181725456098867
COG8-CDG	0.004851759000000001	0.181725456098867
GM2 GANGLIOSIDOSIS, AB VARIANT	0.004851759000000001	0.181725456098867
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.004851759000000001	0.181725456098867
WOLFRAM SYNDROME	0.004851759000000001	0.181725456098867
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.181725456098867
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.004851759000000001	0.181725456098867
RETT SYNDROME; RTT	0.004851759000000001	0.181725456098867
CEREBROTENDINOUS XANTHOMATOSIS	0.004851759000000001	0.181725456098867
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.004851759000000001	0.181725456098867
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.004851759000000001	0.181725456098867
XERODERMA PIGMENTOSUM	0.004851759000000001	0.181725456098867
WHIPPLE DISEASE	0.004851759000000001	0.181725456098867
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.004851759000000001	0.181725456098867
FABRY DISEASE	0.004851759000000001	0.181725456098867
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.004773980000000001	0.17881219840203708
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.004773980000000001	0.17881219840203708
WEYERS ACROFACIAL DYSOSTOSIS	0.004773980000000001	0.17881219840203708
PROXIMAL SYMPHALANGISM	0.004773980000000001	0.17881219840203708
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.004773980000000001	0.17881219840203708
BANKI SYNDROME	0.004773980000000001	0.17881219840203708
ROIFMAN SYNDROME	0.004773980000000001	0.17881219840203708
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.004773980000000001	0.17881219840203708
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.004773980000000001	0.17881219840203708
NOONAN SYNDROME	0.004773980000000001	0.17881219840203708
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.004773980000000001	0.17881219840203708
PERIPHERAL DYSOSTOSIS	0.004773980000000001	0.17881219840203708
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.004773980000000001	0.17881219840203708
FEINGOLD SYNDROME	0.004773980000000001	0.17881219840203708
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.004773980000000001	0.17881219840203708
CLEIDOCRANIAL DYSPLASIA	0.004773980000000001	0.17881219840203708
HAND-FOOT-GENITAL SYNDROME; HFG	0.004773980000000001	0.17881219840203708
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.004773980000000001	0.17881219840203708
MESOMELIA-SYNOSTOSES SYNDROME	0.004773980000000001	0.17881219840203708
TETRALOGY OF FALLOT	0.004773980000000001	0.17881219840203708
HOLOPROSENCEPHALY	0.0047674729999999995	0.1785684749312638
OROFACIODIGITAL SYNDROME TYPE 6	0.0047674729999999995	0.1785684749312638
DISTAL MONOSOMY 10P	0.0046894400000000004	0.1756457035166567
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.0046894400000000004	0.1756457035166567
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0046894400000000004	0.1756457035166567
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0046894400000000004	0.1756457035166567
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0046894400000000004	0.1756457035166567
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.0046894400000000004	0.1756457035166567
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0046894400000000004	0.1756457035166567
FRONTONASAL DYSPLASIA	0.0046894400000000004	0.1756457035166567
RING CHROMOSOME 1 SYNDROME	0.0046894400000000004	0.1756457035166567
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0046894400000000004	0.1756457035166567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.004682933	0.17540198004588342
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004682933	0.17540198004588342
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004682933	0.17540198004588342
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.004682933	0.17540198004588342
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004682933	0.17540198004588342
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.17540198004588342
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004682933	0.17540198004588342
KOOLEN-DE VRIES SYNDROME	0.004682933	0.17540198004588342
CHROMOSOME 10Q26 DELETION SYNDROME	0.004682933	0.17540198004588342
C SYNDROME	0.004682933	0.17540198004588342
8P23.1 MICRODELETION SYNDROME	0.004682933	0.17540198004588342
22Q11.2 DELETION SYNDROME	0.004682933	0.17540198004588342
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.17540198004588342
COFFIN-SIRIS SYNDROME	0.004682933	0.17540198004588342
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004682933	0.17540198004588342
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004682933	0.17540198004588342
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004682933	0.17540198004588342
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.004682933	0.17540198004588342
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.004682933	0.17540198004588342
20P12.3 MICRODELETION SYNDROME	0.004682933	0.17540198004588342
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.17540198004588342
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004682933	0.17540198004588342
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.004610594	0.17269248071404608
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004610594	0.17269248071404608
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.004610594	0.17269248071404608
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004610594	0.17269248071404608
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.004610594	0.17269248071404608
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.004610594	0.17269248071404608
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.004610594	0.17269248071404608
SAUL-WILSON SYNDROME; SWILS	0.004610594	0.17269248071404608
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004610594	0.17269248071404608
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.004610594	0.17269248071404608
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004610594	0.17269248071404608
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.004610594	0.17269248071404608
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004610594	0.17269248071404608
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.004610594	0.17269248071404608
MENTAL RETARDATION, X-LINKED 99	0.004610594	0.17269248071404608
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.004610594	0.17269248071404608
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.004610594	0.17269248071404608
ATKIN-FLAITZ SYNDROME	0.004606459	0.17253760188330267
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.004606459	0.17253760188330267
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.004606459	0.17253760188330267
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.004606459	0.17253760188330267
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.004606459	0.17253760188330267
AICA-RIBOSIDURIA	0.004606459	0.17253760188330267
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004606459	0.17253760188330267
NOONAN SYNDROME 7; NS7	0.004606459	0.17253760188330267
CLARK-BARAITSER SYNDROME	0.004606459	0.17253760188330267
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.004606459	0.17253760188330267
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.004606459	0.17253760188330267
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004559374	0.17077400581424498
TRISOMY 8Q	0.004559374	0.17077400581424498
ELSAHY-WATERS SYNDROME; ESWS	0.004559374	0.17077400581424498
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.004559374	0.17077400581424498
3C SYNDROME	0.004559374	0.17077400581424498
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.004555238999999999	0.17061912698350154
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555238999999999	0.17061912698350154
AYME-GRIPP SYNDROME; AYGRP	0.004555238999999999	0.17061912698350154
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00435612	0.16316100899104763
KEIPERT SYNDROME	0.00435612	0.16316100899104763
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00435612	0.16316100899104763
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00435612	0.16316100899104763
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00435612	0.16316100899104763
FRAXE INTELLECTUAL DISABILITY	0.00435612	0.16316100899104763
WHITE FORELOCK WITH MALFORMATIONS	0.00435612	0.16316100899104763
WILLIAMS-BEUREN SYNDROME; WBS	0.00435612	0.16316100899104763
MONOSOMY 22	0.00435612	0.16316100899104763
PENOSCROTAL TRANSPOSITION	0.00435612	0.16316100899104763
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00435612	0.16316100899104763
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00431034	0.16144629245623912
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.16144629245623912
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00431034	0.16144629245623912
NEUROFERRITINOPATHY	0.00431034	0.16144629245623912
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.16144629245623912
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.16144629245623912
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00431034	0.16144629245623912
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.16144629245623912
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.16144629245623912
DYSOSTEOSCLEROSIS	0.00431034	0.16144629245623912
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.16144629245623912
TRISOMY 5P	0.00431034	0.16144629245623912
HUNTINGTON DISEASE	0.00431034	0.16144629245623912
REFSUM DISEASE	0.00431034	0.16144629245623912
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.16144629245623912
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.16144629245623912
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.16144629245623912
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.16144629245623912
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.16144629245623912
ATAXIA WITH VITAMIN E DEFICIENCY	0.00431034	0.16144629245623912
PANDAS	0.00431034	0.16144629245623912
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.16144629245623912
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004226054	0.15828931128863594
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.15828931128863594
OROFACIODIGITAL SYNDROME VI	0.004226054	0.15828931128863594
PSEUDOAMINOPTERIN SYNDROME	0.004226054	0.15828931128863594
BARATELA-SCOTT SYNDROME	0.004226054	0.15828931128863594
CODAS SYNDROME	0.004226054	0.15828931128863594
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004226054	0.15828931128863594
WOLCOTT-RALLISON SYNDROME	0.004221918999999999	0.15813443245789252
COFFIN-LOWRY SYNDROME	0.004221918999999999	0.15813443245789252
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.004221918999999999	0.15813443245789252
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.15813443245789252
FOUNTAIN SYNDROME	0.004221918999999999	0.15813443245789252
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004221918999999999	0.15813443245789252
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004141514	0.15512281640325556
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514	0.15512281640325556
JOUBERT SYNDROME 10	0.004141514	0.15512281640325556
8Q12 MICRODUPLICATION SYNDROME	0.004141514	0.15512281640325556
CHROMOSOME 16Q22 DELETION SYNDROME	0.004141514	0.15512281640325556
CHROMOSOME 9P DELETION SYNDROME	0.004141514	0.15512281640325556
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.004141514	0.15512281640325556
COHEN-GIBSON SYNDROME; COGIS	0.004141514	0.15512281640325556
NOONAN SYNDROME 6; NS6	0.004141514	0.15512281640325556
LAMB-SHAFFER SYNDROME	0.004141514	0.15512281640325556
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514	0.15512281640325556
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.004141514	0.15512281640325556
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.004141514	0.15512281640325556
CEREBROFACIOARTICULAR SYNDROME	0.004141514	0.15512281640325556
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.004137379	0.15496793757251218
HENNEKAM SYNDROME	0.004137379	0.15496793757251218
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.004137379	0.15496793757251218
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.004137379	0.15496793757251218
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.004137379	0.15496793757251218
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.004137379	0.15496793757251218
LATHOSTEROLOSIS	0.004137379	0.15496793757251218
MOWAT-WILSON SYNDROME	0.004137379	0.15496793757251218
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00406504	0.1522584382406748
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00406504	0.1522584382406748
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00406504	0.1522584382406748
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00406504	0.1522584382406748
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00406504	0.1522584382406748
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00406504	0.1522584382406748
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00406504	0.1522584382406748
MENTAL RETARDATION, X-LINKED 93	0.00406504	0.1522584382406748
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00406504	0.1522584382406748
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00406504	0.1522584382406748
TRICHOHEPATOENTERIC SYNDROME 1	0.00406504	0.1522584382406748
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.1522584382406748
TRICHOHEPATOENTERIC SYNDROME 2	0.00406504	0.1522584382406748
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00406504	0.1522584382406748
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00406504	0.1522584382406748
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.1522584382406748
MARSHALL-SMITH SYNDROME	0.00406504	0.1522584382406748
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00406504	0.1522584382406748
FG SYNDROME 2; FGS2	0.00406504	0.1522584382406748
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.1522584382406748
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00406504	0.1522584382406748
TETRASOMY 12P	0.00406504	0.1522584382406748
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00406504	0.1522584382406748
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.1522584382406748
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00406504	0.1522584382406748
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.1522584382406748
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00406504	0.1522584382406748
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00406504	0.1522584382406748
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00406504	0.1522584382406748
OSTEOGENESIS IMPERFECTA, TYPE X	0.00406504	0.1522584382406748
MENTAL RETARDATION, X-LINKED 19	0.00406504	0.1522584382406748
268650 RUDIGER SYNDROME	0.00406504	0.1522584382406748
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00406504	0.1522584382406748
MARSHALL-SMITH SYNDROME; MRSHSS	0.00406504	0.1522584382406748
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.1522584382406748
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.1503399633408737
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0040138199999999995	0.1503399633408737
CHARLIE M SYNDROME	0.0040138199999999995	0.1503399633408737
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.1503399633408737
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.1503399633408737
BASAL CELL NEVUS SYNDROME	0.0040138199999999995	0.1503399633408737
608028 THAI SYMPHALANGISM SYNDROME	0.0040138199999999995	0.1503399633408737
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.1503399633408737
ACROOSTEOLYSIS DOMINANT TYPE	0.0040138199999999995	0.1503399633408737
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.1503399633408737
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0040138199999999995	0.1503399633408737
GENITOPALATOCARDIAC SYNDROME	0.0040138199999999995	0.1503399633408737
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0040138199999999995	0.1503399633408737
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.1503399633408737
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0040138199999999995	0.1503399633408737
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.1503399633408737
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.0040138199999999995	0.1503399633408737
ROBERTS SYNDROME; RBS	0.0040138199999999995	0.1503399633408737
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.1503399633408737
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.1503399633408737
MULTIPLE METAPHYSEAL DYSPLASIA	0.0040138199999999995	0.1503399633408737
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0040138199999999995	0.1503399633408737
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0040138199999999995	0.1503399633408737
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0040138199999999995	0.1503399633408737
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0040138199999999995	0.1503399633408737
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0040138199999999995	0.1503399633408737
CATEL-MANZKE SYNDROME; CATMANS	0.003811773	0.1427721754049091
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.003811773	0.1427721754049091
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.003811773	0.1427721754049091
COHEN SYNDROME	0.003811773	0.1427721754049091
RECOMBINANT CHROMOSOME 8 SYNDROME	0.003811773	0.1427721754049091
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.003811773	0.1427721754049091
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.003811773	0.1427721754049091
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.003811773	0.1427721754049091
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.003811773	0.1427721754049091
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.003811773	0.1427721754049091
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.003811773	0.1427721754049091
RECOMBINANT 8 SYNDROME	0.003811773	0.1427721754049091
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.003811773	0.1427721754049091
CHROMOSOME 16P13.2 DELETION SYNDROME	0.003811773	0.1427721754049091
DPAGT1-CDG	0.003811773	0.1427721754049091
CHROMOSOME 16P13.3 DELETION SYNDROME	0.003811773	0.1427721754049091
ACROCEPHALOPOLYDACTYLY	0.0036804999999999997	0.1378552688152647
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.1378552688152647
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.1378552688152647
16P12.1P12.3 TRIPLICATION SYNDROME	0.0036804999999999997	0.1378552688152647
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.0036804999999999997	0.1378552688152647
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0036804999999999997	0.1378552688152647
MOEBIUS SYNDROME; MBS	0.0036804999999999997	0.1378552688152647
FRONTORHINY	0.0036804999999999997	0.1378552688152647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.1378552688152647
CAREY-FINEMAN-ZITER SYNDROME	0.0036804999999999997	0.1378552688152647
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0036804999999999997	0.1378552688152647
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.1378552688152647
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.1378552688152647
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0036804999999999997	0.1378552688152647
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0036804999999999997	0.1378552688152647
DISTAL TRISOMY 5Q	0.0036804999999999997	0.1378552688152647
LAURENCE-MOON SYNDROME	0.0036804999999999997	0.1378552688152647
SILLENCE SYNDROME	0.0036804999999999997	0.1378552688152647
OROFACIODIGITAL SYNDROME IV; OFD4	0.0036804999999999997	0.1378552688152647
ABRUZZO-ERICKSON SYNDROME	0.0036804999999999997	0.1378552688152647
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0036804999999999997	0.1378552688152647
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.1378552688152647
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00359596	0.13468877392988432
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00359596	0.13468877392988432
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.13468877392988432
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.13468877392988432
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00359596	0.13468877392988432
CRI-DU-CHAT SYNDROME	0.00359596	0.13468877392988432
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00359596	0.13468877392988432
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00359596	0.13468877392988432
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00359596	0.13468877392988432
MONOSOMY 5P	0.00359596	0.13468877392988432
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.13468877392988432
RING CHROMOSOME 13 SYNDROME	0.00359596	0.13468877392988432
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00359596	0.13468877392988432
SHPRINTZEN OMPHALOCELE SYNDROME	0.00359596	0.13468877392988432
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00359596	0.13468877392988432
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00359596	0.13468877392988432
SCARF SYNDROME	0.00359596	0.13468877392988432
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00359596	0.13468877392988432
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00359596	0.13468877392988432
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00359596	0.13468877392988432
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00359596	0.13468877392988432
JOUBERT SYNDROME 3; JBTS3	0.00359596	0.13468877392988432
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00359596	0.13468877392988432
600736 VELOFACIOSKELETAL SYNDROME	0.00359596	0.13468877392988432
RING CHROMOSOME 6 SYNDROME	0.00359596	0.13468877392988432
OMODYSPLASIA 1; OMOD1	0.00359596	0.13468877392988432
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00359596	0.13468877392988432
3Q13 MICRODELETION SYNDROME	0.00359596	0.13468877392988432
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.13468877392988432
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0032703540000000005	0.12249301176228126
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0032703540000000005	0.12249301176228126
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032703540000000005	0.12249301176228126
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0032703540000000005	0.12249301176228126
3Q29 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228126
17P13.3 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.12249301176228126
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0032703540000000005	0.12249301176228126
2Q32Q33 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228126
CHAR SYNDROME	0.0032703540000000005	0.12249301176228126
EAR-PATELLA-SHORT STATURE SYNDROME	0.0032703540000000005	0.12249301176228126
SILVER-RUSSELL SYNDROME; SRS	0.0032703540000000005	0.12249301176228126
12Q14 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228126
DISTAL TRISOMY 18Q	0.0032703540000000005	0.12249301176228126
OCULOFACIOCARDIODENTAL SYNDROME	0.0032703540000000005	0.12249301176228126
CHAR SYNDROME	0.0032703540000000005	0.12249301176228126
POPOV-CHANG SYNDROME; POPCHAS	0.0032703540000000005	0.12249301176228126
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.0032662190000000003	0.12233813293153785
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0032662190000000003	0.12233813293153785
BOWEN-CONRADI SYNDROME	0.0032662190000000003	0.12233813293153785
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.0032662190000000003	0.12233813293153785
WARBURG MICRO SYNDROME 3; WARBM3	0.0032662190000000003	0.12233813293153785
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.0032662190000000003	0.12233813293153785
MICROPHTHALMIA, LENZ TYPE	0.0032662190000000003	0.12233813293153785
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0032662190000000003	0.12233813293153785
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0032662190000000003	0.12233813293153785
SECKEL SYNDROME 1; SCKL1	0.0032662190000000003	0.12233813293153785
BRANCHIOOCULOFACIAL SYNDROME	0.0032662190000000003	0.12233813293153785
PROTEUS SYNDROME	0.0032662190000000003	0.12233813293153785
CORNELIA DE LANGE SYNDROME 1	0.0032662190000000003	0.12233813293153785
SCHAAF-YANG SYNDROME; SHFYNG	0.003136153	0.11746643522912617
COWDEN SYNDROME	0.003136153	0.11746643522912617
TEMTAMY SYNDROME; TEMTYS	0.003136153	0.11746643522912617
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.003136153	0.11746643522912617
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.003136153	0.11746643522912617
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.003136153	0.11746643522912617
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.003136153	0.11746643522912617
COFFIN-SIRIS SYNDROME 2; CSS2	0.003136153	0.11746643522912617
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.003136153	0.11746643522912617
ADAMS-OLIVER SYNDROME 1; AOS1	0.003136153	0.11746643522912617
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.003136153	0.11746643522912617
MYHRE SYNDROME	0.0031361529999999996	0.11746643522912614
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003051613	0.11429994034374577
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.003051613	0.11429994034374577
MENTAL RETARDATION, X-LINKED 104; MRX104	0.003051613	0.11429994034374577
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.003051613	0.11429994034374577
3Q29 MICRODUPLICATION SYNDROME	0.003051613	0.11429994034374577
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.003051613	0.11429994034374577
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003051613	0.11429994034374577
BOHRING-OPITZ SYNDROME	0.003051613	0.11429994034374577
MICRO SYNDROME	0.003051613	0.11429994034374577
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.003051613	0.11429994034374577
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.003051613	0.11429994034374577
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.003051613	0.11429994034374577
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.003051613	0.11429994034374577
MOSAIC TRISOMY 14	0.003051613	0.11429994034374577
CHROMOSOME 1P35 DELETION SYNDROME	0.003051613	0.11429994034374577
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.003051613	0.11429994034374577
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003051613	0.11429994034374577
TARP SYNDROME	0.003051613	0.11429994034374577
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.003051613	0.11429994034374577
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.003051613	0.11429994034374577
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.003051613	0.11429994034374577
KABUKI SYNDROME 1	0.003051613	0.11429994034374577
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.003051613	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.003051613	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.003051613	0.11429994034374577
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003051613	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.003051613	0.11429994034374577
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027248000000000003	0.10205896928891002
WT LIMB-BLOOD SYNDROME	0.0027248000000000003	0.10205896928891002
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0027248000000000003	0.10205896928891002
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0027248000000000003	0.10205896928891002
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.0027248000000000003	0.10205896928891002
GORDON SYNDROME	0.0027248000000000003	0.10205896928891002
TALONAVICULAR COALITION	0.0027248000000000003	0.10205896928891002
FIBROCHONDROGENESIS 1; FBCG1	0.0027248000000000003	0.10205896928891002
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0027248000000000003	0.10205896928891002
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0027248000000000003	0.10205896928891002
MEIER-GORLIN SYNDROME 1; MGORS1	0.0027248000000000003	0.10205896928891002
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0027248000000000003	0.10205896928891002
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0027248000000000003	0.10205896928891002
JOHANSON-BLIZZARD SYNDROME; JBS	0.0027248000000000003	0.10205896928891002
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0027248000000000003	0.10205896928891002
3MC SYNDROME 1	0.0027248000000000003	0.10205896928891002
MICROCEPHALY-CARDIOMYOPATHY	0.0027248000000000003	0.10205896928891002
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027248000000000003	0.10205896928891002
MASA SYNDROME	0.0027248000000000003	0.10205896928891002
DENTAL ANKYLOSIS	0.0027248000000000003	0.10205896928891002
HAND-FOOT-GENITAL SYNDROME	0.0027248000000000003	0.10205896928891002
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0027248000000000003	0.10205896928891002
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0027248000000000003	0.10205896928891002
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0027248000000000003	0.10205896928891002
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0027248000000000003	0.10205896928891002
19Q13.11 MICRODELETION SYNDROME	0.0027248000000000003	0.10205896928891002
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0027248000000000003	0.10205896928891002
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.0027248000000000003	0.10205896928891002
HALLUX VARUS-PREAXIAL POLYSYNDACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
BRACHYDACTYLY TYPE C	0.0027248000000000003	0.10205896928891002
BRACHYDACTYLY TYPE A1	0.0027248000000000003	0.10205896928891002
BRACHYDACTYLY TYPE A2	0.0027248000000000003	0.10205896928891002
BRACHYDACTYLY TYPE A7	0.0027248000000000003	0.10205896928891002
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0027248000000000003	0.10205896928891002
HALLERMANN-STREIFF SYNDROME	0.0027248000000000003	0.10205896928891002
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0027248000000000003	0.10205896928891002
BLOOM SYNDROME	0.0027248000000000003	0.10205896928891002
BOWEN-CONRADI SYNDROME	0.0027248000000000003	0.10205896928891002
TETRALOGY OF FALLOT	0.0027248000000000003	0.10205896928891002
ANONYCHIA-MICROCEPHALY SYNDROME	0.0027248000000000003	0.10205896928891002
SYNDACTYLY TYPE 5	0.0027248000000000003	0.10205896928891002
SYNDACTYLY TYPE 2	0.0027248000000000003	0.10205896928891002
MOSAIC TRISOMY 8	0.0027248000000000003	0.10205896928891002
NAIL-PATELLA SYNDROME	0.0027248000000000003	0.10205896928891002
CEREBROCOSTOMANDIBULAR SYNDROME	0.0027248000000000003	0.10205896928891002
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.0027248000000000003	0.10205896928891002
HUNTER-MACDONALD SYNDROME	0.0027248000000000003	0.10205896928891002
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928891002
TOWNES-BROCKS SYNDROME	0.0027248000000000003	0.10205896928891002
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928891002
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0027248000000000003	0.10205896928891002
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0027248000000000003	0.10205896928891002
SECKEL SYNDROME 5; SCKL5	0.0027248000000000003	0.10205896928891002
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0027248000000000003	0.10205896928891002
BRACHYDACTYLY, TYPE A3	0.0027248000000000003	0.10205896928891002
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0027248000000000003	0.10205896928891002
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0027248000000000003	0.10205896928891002
OSLAM SYNDROME	0.0027248000000000003	0.10205896928891002
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.0027248000000000003	0.10205896928891002
ALAGILLE SYNDROME	0.0027248000000000003	0.10205896928891002
PELVIS-SHOULDER DYSPLASIA	0.0027248000000000003	0.10205896928891002
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928891002
DESBUQUOIS SYNDROME	0.0027248000000000003	0.10205896928891002
MOLAR I REINCLUSION	0.0027248000000000003	0.10205896928891002
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.10205896928891002
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.0027248000000000003	0.10205896928891002
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0027248000000000003	0.10205896928891002
BRACHYDACTYLY, TYPE A2; BDA2	0.0027248000000000003	0.10205896928891002
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0027248000000000003	0.10205896928891002
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0027248000000000003	0.10205896928891002
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0027248000000000003	0.10205896928891002
LIMB-MAMMARY SYNDROME	0.0027248000000000003	0.10205896928891002
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.0027248000000000003	0.10205896928891002
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.0027248000000000003	0.10205896928891002
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0027248000000000003	0.10205896928891002
SYNPOLYDACTYLY 1	0.0027248000000000003	0.10205896928891002
ERMINE PHENOTYPE	0.0027248000000000003	0.10205896928891002
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.10205896928891002
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0027248000000000003	0.10205896928891002
SECKEL SYNDROME 2; SCKL2	0.0027248000000000003	0.10205896928891002
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.0027248000000000003	0.10205896928891002
3M SYNDROME	0.0027248000000000003	0.10205896928891002
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0027248000000000003	0.10205896928891002
METATROPIC DYSPLASIA	0.0027248000000000003	0.10205896928891002
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0027248000000000003	0.10205896928891002
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027248000000000003	0.10205896928891002
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.0027248000000000003	0.10205896928891002
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928891002
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0027248000000000003	0.10205896928891002
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.0027248000000000003	0.10205896928891002
CATEL-MANZKE SYNDROME	0.0027248000000000003	0.10205896928891002
FETAL MINOXIDIL SYNDROME	0.0027248000000000003	0.10205896928891002
BRACHYDACTYLY, TYPE A1, D	0.0027248000000000003	0.10205896928891002
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0027248000000000003	0.10205896928891002
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
FLOATING-HARBOR SYNDROME	0.0027248000000000003	0.10205896928891002
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002718293	0.10181524581813677
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.002718293	0.10181524581813677
MONOSOMY 18Q	0.002718293	0.10181524581813677
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002718293	0.10181524581813677
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002718293	0.10181524581813677
MENTAL RETARDATION, X-LINKED 91; MRX91	0.002718293	0.10181524581813677
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813677
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.10181524581813677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.002718293	0.10181524581813677
WEAVER SYNDROME	0.002718293	0.10181524581813677
LATHOSTEROLOSIS	0.002718293	0.10181524581813677
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002718293	0.10181524581813677
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002718293	0.10181524581813677
MONOSOMY 9P	0.002718293	0.10181524581813677
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002718293	0.10181524581813677
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.10181524581813677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002718293	0.10181524581813677
XQ25 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813677
POTOCKI-SHAFFER SYNDROME	0.002718293	0.10181524581813677
CK SYNDROME	0.002718293	0.10181524581813677
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.10181524581813677
MONOSOMY 9Q22.3	0.002718293	0.10181524581813677
8P11.2 DELETION SYNDROME	0.002718293	0.10181524581813677
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.002718293	0.10181524581813677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.10181524581813677
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.10181524581813677
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002718293	0.10181524581813677
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002718293	0.10181524581813677
DISTAL TRISOMY 17Q	0.002718293	0.10181524581813677
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002718293	0.10181524581813677
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002718293	0.10181524581813677
XQ25 DUPLICATION SYNDROME	0.002718293	0.10181524581813677
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002718293	0.10181524581813677
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.10181524581813677
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002718293	0.10181524581813677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002718293	0.10181524581813677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002718293	0.10181524581813677
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.002718293	0.10181524581813677
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002718293	0.10181524581813677
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.002718293	0.10181524581813677
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002718293	0.10181524581813677
PEHO SYNDROME; PEHO	0.002718293	0.10181524581813677
22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813677
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.0971872715864983
BARDET-BIEDL SYNDROME 1; BBS1	0.0025947339999999996	0.0971872715864983
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0025947339999999996	0.0971872715864983
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0025947339999999996	0.0971872715864983
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.0971872715864983
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.0971872715864983
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.0971872715864983
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.0971872715864983
GENITOPATELLAR SYNDROME; GTPTS	0.0025947339999999996	0.0971872715864983
20Q11.2 MICRODELETION SYNDROME	0.0025947339999999996	0.0971872715864983
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0025947339999999996	0.0971872715864983
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0025947339999999996	0.0971872715864983
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.0971872715864983
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.0971872715864983
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.0971872715864983
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.0971872715864983
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0025947339999999996	0.0971872715864983
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.0971872715864983
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.0971872715864983
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.002590599	0.0970323927557549
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.002590599	0.0970323927557549
PGM3-CDG	0.002590599	0.0970323927557549
CONO-SPONDYLAR DYSPLASIA	0.002590599	0.0970323927557549
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.002590599	0.0970323927557549
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.0970323927557549
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.0970323927557549
KLEEFSTRA SYNDROME	0.002590599	0.0970323927557549
21Q22.11Q22.12 MICRODELETION SYNDROME	0.002590599	0.0970323927557549
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.002590599	0.0970323927557549
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.0970323927557549
CRANIOSYNOSTOSIS 2	0.002590599	0.0970323927557549
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.002590599	0.0970323927557549
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002590599	0.0970323927557549
ADAMS-OLIVER SYNDROME 5; AOS5	0.002590599	0.0970323927557549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.002590599	0.0970323927557549
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002590599	0.0970323927557549
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.0970323927557549
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.002590599	0.0970323927557549
SWEENEY-COX SYNDROME; SWCOS	0.0025101940000000003	0.09402077670111794
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.09402077670111794
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0025101940000000003	0.09402077670111794
GOLDBERG-SHPRINTZEN SYNDROME	0.0025101940000000003	0.09402077670111794
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0025101940000000003	0.09402077670111794
HURLER SYNDROME	0.0025101940000000003	0.09402077670111794
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.09402077670111794
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.09402077670111794
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.09402077670111794
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.0025101940000000003	0.09402077670111794
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.09402077670111794
8Q22.1 MICRODELETION SYNDROME	0.0025101940000000003	0.09402077670111794
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0025101940000000003	0.09402077670111794
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0025101940000000003	0.09402077670111794
TREACHER-COLLINS SYNDROME	0.0025101940000000003	0.09402077670111794
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0025101940000000003	0.09402077670111794
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.09402077670111794
CHROMOSOME 18P DELETION SYNDROME	0.0025101940000000003	0.09402077670111794
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.09402077670111794
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.09402077670111794
GERMAN SYNDROME	0.0025101940000000003	0.09402077670111794
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.09402077670111794
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.09402077670111794
TARP SYNDROME; TARPS	0.0025101940000000003	0.09402077670111794
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.09386589787037453
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.09386589787037453
ACROCARDIOFACIAL SYNDROME	0.002506059	0.09386589787037453
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002506059	0.09386589787037453
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.09386589787037453
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002506059	0.09386589787037453
SPINOCEREBELLAR ATAXIA 47; SCA47	0.002506059	0.09386589787037453
17Q24.2 MICRODELETION SYNDROME	0.002506059	0.09386589787037453
PITT-HOPKINS SYNDROME	0.002506059	0.09386589787037453
FRYNS SYNDROME; FRNS	0.002506059	0.09386589787037453
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.002506059	0.09386589787037453
SIALIDOSIS TYPE 1	0.002506059	0.09386589787037453
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.002506059	0.09386589787037453
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.09386589787037453
LISSENCEPHALY, X-LINKED, 2	0.002506059	0.09386589787037453
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.002506059	0.09386589787037453
ZLOTOGORA-OGUR SYNDROME	0.002506059	0.09386589787037453
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.09386589787037453
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002506059	0.09386589787037453
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.002506059	0.09386589787037453
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.002506059	0.09386589787037453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.002506059	0.09386589787037453
GLUTAMINE DEFICIENCY, CONGENITAL	0.002506059	0.09386589787037453
FILIPPI SYNDROME; FLPIS	0.002506059	0.09386589787037453
311450 PALLISTER W SYNDROME;;W SYNDROME	0.002506059	0.09386589787037453
ASPARTYLGLUCOSAMINURIA	0.002506059	0.09386589787037453
RING CHROMOSOME 10 SYNDROME	0.002506059	0.09386589787037453
COFS SYNDROME	0.002506059	0.09386589787037453
ZIMMERMANN-LABAND SYNDROME 1	0.002506059	0.09386589787037453
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.0815360821755089
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.0815360821755089
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0021768739999999996	0.0815360821755089
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021768739999999996	0.0815360821755089
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.0815360821755089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.0815360821755089
JOUBERT SYNDROME 14	0.0021768739999999996	0.0815360821755089
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.0815360821755089
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.0815360821755089
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.0815360821755089
HADZISELIMOVIC SYNDROME	0.0021768739999999996	0.0815360821755089
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.0815360821755089
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.0815360821755089
TOLUENE EMBRYOPATHY	0.0021768739999999996	0.0815360821755089
MONOSOMY 13Q34	0.0021768739999999996	0.0815360821755089
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.0815360821755089
WARSAW BREAKAGE SYNDROME; WABS	0.0021768739999999996	0.0815360821755089
FETAL HYDANTOIN SYNDROME	0.0021768739999999996	0.0815360821755089
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.0815360821755089
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021768739999999996	0.0815360821755089
48,XYYY SYNDROME	0.0021768739999999996	0.0815360821755089
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.0815360821755089
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0021768739999999996	0.0815360821755089
ROTHMUND-THOMSON SYNDROME	0.0021768739999999996	0.0815360821755089
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.0815360821755089
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.0815360821755089
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.0815360821755089
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.0815360821755089
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0021768739999999996	0.0815360821755089
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.0815360821755089
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.0815360821755089
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0021768739999999996	0.0815360821755089
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.0815360821755089
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.0815360821755089
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.0815360821755089
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.0815360821755089
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.0815360821755089
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0021768739999999996	0.0815360821755089
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.0815360821755089
16P11.2P12.2 MICRODELETION SYNDROME	0.0021768739999999996	0.0815360821755089
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021768739999999996	0.0815360821755089
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.0815360821755089
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.0815360821755089
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.0815360821755089
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.0815360821755089
ICF SYNDROME	0.0021768739999999996	0.0815360821755089
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.0815360821755089
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021768739999999996	0.0815360821755089
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.0815360821755089
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.0815360821755089
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0021768739999999996	0.0815360821755089
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002172739	0.0813812033447655
TETRASOMY 18P	0.002172739	0.0813812033447655
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002172739	0.0813812033447655
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.002172739	0.0813812033447655
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.0813812033447655
MARDEN-WALKER SYNDROME	0.002172739	0.0813812033447655
KNOBLOCH SYNDROME	0.002172739	0.0813812033447655
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002172739	0.0813812033447655
MOMO SYNDROME	0.002172739	0.0813812033447655
CHROMOSOME 18Q DELETION SYNDROME	0.002172739	0.0813812033447655
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002172739	0.0813812033447655
MECKEL SYNDROME, TYPE 10; MKS10	0.002172739	0.0813812033447655
CHIME SYNDROME	0.002172739	0.0813812033447655
OCULODENTODIGITAL DYSPLASIA; ODDD	0.002172739	0.0813812033447655
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002172739	0.0813812033447655
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002172739	0.0813812033447655
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.002172739	0.0813812033447655
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.0813812033447655
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.0813812033447655
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.07675322911312704
SMITH-MAGENIS SYNDROME	0.00204918	0.07675322911312704
GREENBERG DYSPLASIA	0.00204918	0.07675322911312704
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.07675322911312704
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.07675322911312704
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.07675322911312704
EMERY-NELSON SYNDROME	0.00204918	0.07675322911312704
HEART-HAND SYNDROME TYPE 2	0.00204918	0.07675322911312704
SYMPHALANGISM, DISTAL	0.00204918	0.07675322911312704
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.07675322911312704
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.07675322911312704
2Q37 MONOSOMY	0.00204918	0.07675322911312704
SYNDACTYLY, TYPE V	0.00204918	0.07675322911312704
PSEUDOACHONDROPLASIA	0.00204918	0.07675322911312704
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.07675322911312704
CARPENTER SYNDROME	0.00204918	0.07675322911312704
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.07675322911312704
HEART-HAND SYNDROME TYPE 3	0.00204918	0.07675322911312704
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.07675322911312704
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312704
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.07675322911312704
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.07675322911312704
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.07675322911312704
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00204918	0.07675322911312704
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.07675322911312704
ACROMICRIC DYSPLASIA	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.07675322911312704
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.07675322911312704
BRACHYDACTYLY, TYPE E	0.00204918	0.07675322911312704
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.07675322911312704
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.07675322911312704
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.07675322911312704
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.07675322911312704
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00204918	0.07675322911312704
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.07675322911312704
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.07675322911312704
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312704
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.07675322911312704
CLEIDOCRANIAL DYSPLASIA; CCD	0.00204918	0.07675322911312704
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00204918	0.07675322911312704
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.07675322911312704
COOKS SYNDROME	0.00204918	0.07675322911312704
ENG-STROM SYNDROME	0.00204918	0.07675322911312704
SHORT RIB-POLYDACTYLY SYNDROME	0.00204918	0.07675322911312704
PYCNODYSOSTOSIS	0.00204918	0.07675322911312704
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.07675322911312704
LOWRY-WOOD SYNDROME	0.00204918	0.07675322911312704
METATROPIC DYSPLASIA	0.00204918	0.07675322911312704
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.07675322911312704
ATELOSTEOGENESIS TYPE I	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.07675322911312704
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.07675322911312704
JEUNE SYNDROME	0.00204918	0.07675322911312704
HYPOCHONDROPLASIA	0.00204918	0.07675322911312704
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00204918	0.07675322911312704
AREDYLD SYNDROME	0.00204918	0.07675322911312704
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.07675322911312704
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.07675322911312704
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00204918	0.07675322911312704
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.07675322911312704
SATOYOSHI SYNDROME	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.07675322911312704
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.07675322911312704
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.07675322911312704
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.07675322911312704
PYCNODYSOSTOSIS	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.07675322911312704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.07675322911312704
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.07675322911312704
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.07675322911312704
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.07675322911312704
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.07675322911312704
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00204918	0.07675322911312704
ISOLATED BRACHYCEPHALY	0.00204918	0.07675322911312704
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.07675322911312704
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.07675322911312704
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.07675322911312704
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00204918	0.07675322911312704
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.07675322911312704
LARON SYNDROME	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.07675322911312704
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.07675322911312704
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME	0.00204918	0.07675322911312704
PELVISCAPULAR DYSPLASIA	0.00204918	0.07675322911312704
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.07675322911312704
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.07675322911312704
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.07675322911312704
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.07675322911312704
EIKEN SYNDROME	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.07675322911312704
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.07675322911312704
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.07675322911312704
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.07675322911312704
LETHAL KNIEST-LIKE DYSPLASIA	0.00204918	0.07675322911312704
OPSISMODYSPLASIA	0.00204918	0.07675322911312704
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00204918	0.07675322911312704
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.07675322911312704
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00204918	0.07675322911312704
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312704
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME 2	0.00204918	0.07675322911312704
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.07675322911312704
RIN2 SYNDROME	0.00204918	0.07675322911312704
MAL DE MELEDA	0.00204918	0.07675322911312704
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00204918	0.07675322911312704
RADIO-RENAL SYNDROME	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.07675322911312704
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.07675322911312704
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.07675322911312704
HYPOCHONDROPLASIA	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.07675322911312704
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.07675322911312704
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00204918	0.07675322911312704
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312704
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.07675322911312704
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.07675322911312704
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312704
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.07675322911312704
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00204918	0.07675322911312704
CHITAYAT SYNDROME	0.00204918	0.07675322911312704
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.07675322911312704
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00204918	0.07675322911312704
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.07675322911312704
MACS SYNDROME	0.00204918	0.07675322911312704
INFANTILE SYSTEMIC HYALINOSIS	0.00204918	0.07675322911312704
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.07675322911312704
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.07675322911312704
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.07675322911312704
DESBUQUOIS DYSPLASIA 1	0.00204918	0.07675322911312704
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.07675322911312704
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.07675322911312704
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.07675322911312704
FOCAL DERMAL HYPOPLASIA; FDH	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.07675322911312704
RHYNS SYNDROME; RHYNS	0.00204918	0.07675322911312704
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.07675322911312704
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.07675322911312704
GRANGE SYNDROME; GRNG	0.00204918	0.07675322911312704
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.07675322911312704
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.07675322911312704
LERI PLEONOSTEOSIS	0.00204918	0.07675322911312704
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.07358673422774668
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00196464	0.07358673422774668
OTOPALATODIGITAL SYNDROME TYPE 1	0.00196464	0.07358673422774668
FRONTOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774668
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.07358673422774668
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00196464	0.07358673422774668
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.07358673422774668
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00196464	0.07358673422774668
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00196464	0.07358673422774668
SIMOSA CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774668
WAARDENBURG SYNDROME	0.00196464	0.07358673422774668
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.07358673422774668
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774668
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00196464	0.07358673422774668
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00196464	0.07358673422774668
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00196464	0.07358673422774668
MARSHALL SYNDROME	0.00196464	0.07358673422774668
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00196464	0.07358673422774668
COG1-CDG	0.00196464	0.07358673422774668
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.07358673422774668
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.07358673422774668
WAARDENBURG-SHAH SYNDROME	0.00196464	0.07358673422774668
ISOLATED TRIGONOCEPHALY	0.00196464	0.07358673422774668
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00196464	0.07358673422774668
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.07358673422774668
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00196464	0.07358673422774668
MULIBREY NANISM	0.00196464	0.07358673422774668
BRANCHIO-OCULO-FACIAL SYNDROME	0.00196464	0.07358673422774668
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.07358673422774668
TRISOMY 18-LIKE SYNDROME	0.00196464	0.07358673422774668
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00196464	0.07358673422774668
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00196464	0.07358673422774668
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.07358673422774668
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.07358673422774668
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774668
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.07358673422774668
ADULT SYNDROME	0.00196464	0.07358673422774668
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.07358673422774668
SCLEROSTEOSIS 1; SOST1	0.00196464	0.07358673422774668
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00196464	0.07358673422774668
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00196464	0.07358673422774668
JUNG SYNDROME	0.00196464	0.07358673422774668
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.07358673422774668
NEONATAL MARFAN SYNDROME	0.00196464	0.07358673422774668
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.07358673422774668
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00196464	0.07358673422774668
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.07358673422774668
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00196464	0.07358673422774668
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774668
BOOMERANG DYSPLASIA	0.00196464	0.07358673422774668
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.07358673422774668
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.07358673422774668
RETINITIS PIGMENTOSA	0.00196464	0.07358673422774668
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.07358673422774668
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774668
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00196464	0.07358673422774668
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00196464	0.07358673422774668
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.07358673422774668
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00196464	0.07358673422774668
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00196464	0.07358673422774668
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00196464	0.07358673422774668
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.07358673422774668
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00196464	0.07358673422774668
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.07358673422774668
STROMME SYNDROME; STROMS	0.00196464	0.07358673422774668
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.07358673422774668
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774668
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00196464	0.07358673422774668
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774668
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00196464	0.07358673422774668
MEGALENCEPHALY	0.00196464	0.07358673422774668
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.07358673422774668
BARBER-SAY SYNDROME	0.00196464	0.07358673422774668
SHELDON-HALL SYNDROME	0.00196464	0.07358673422774668
MOSAIC TRISOMY 1	0.00196464	0.07358673422774668
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00196464	0.07358673422774668
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.07358673422774668
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00196464	0.07358673422774668
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.07358673422774668
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00196464	0.07358673422774668
FRASER SYNDROME	0.00196464	0.07358673422774668
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774668
TRISOMY 18P	0.00196464	0.07358673422774668
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774668
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.07358673422774668
EPICANTHUS	0.00163132	0.06110203970213765
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00163132	0.06110203970213765
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.06110203970213765
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.06110203970213765
BRADDOCK SYNDROME	0.00163132	0.06110203970213765
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00163132	0.06110203970213765
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.06110203970213765
FETAL VALPROATE SYNDROME	0.00163132	0.06110203970213765
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.06110203970213765
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.06110203970213765
MYOTONIA PERMANENS	0.00163132	0.06110203970213765
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00163132	0.06110203970213765
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.06110203970213765
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00163132	0.06110203970213765
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.06110203970213765
LEGIUS SYNDROME	0.00163132	0.06110203970213765
COSTELLO SYNDROME	0.00163132	0.06110203970213765
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.06110203970213765
STICKLER SYNDROME	0.00163132	0.06110203970213765
SCARF SYNDROME	0.00163132	0.06110203970213765
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.06110203970213765
NOONAN SYNDROME 8; NS8	0.00163132	0.06110203970213765
TRISOMY XQ28	0.00163132	0.06110203970213765
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.06110203970213765
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.06110203970213765
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.06110203970213765
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.06110203970213765
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00163132	0.06110203970213765
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.06110203970213765
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.06110203970213765
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.06110203970213765
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213765
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.06110203970213765
PHAVER SYNDROME	0.00163132	0.06110203970213765
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.06110203970213765
EHLERS-DANLOS SYNDROME, TYPE I	0.00163132	0.06110203970213765
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.06110203970213765
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00163132	0.06110203970213765
ACROOTOOCULAR SYNDROME	0.00163132	0.06110203970213765
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.06110203970213765
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.06110203970213765
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.06110203970213765
BALLER-GEROLD SYNDROME	0.00163132	0.06110203970213765
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.06110203970213765
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.06110203970213765
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00163132	0.06110203970213765
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.06110203970213765
SCHOLTE SYNDROME; SHLTS	0.00163132	0.06110203970213765
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.06110203970213765
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.06110203970213765
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.06110203970213765
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.06110203970213765
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.06110203970213765
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.06110203970213765
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.06110203970213765
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.06110203970213765
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.06110203970213765
MARTSOLF SYNDROME	0.00163132	0.06110203970213765
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.06110203970213765
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.06110203970213765
BRITTLE CORNEA SYNDROME	0.00163132	0.06110203970213765
LICHTENSTEIN SYNDROME	0.00163132	0.06110203970213765
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.06110203970213765
EHLERS-DANLOS SYNDROME, TYPE VI	0.00163132	0.06110203970213765
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.06110203970213765
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.06110203970213765
JUBERG-MARSIDI SYNDROME	0.00163132	0.06110203970213765
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00163132	0.06110203970213765
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.06110203970213765
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213765
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.06110203970213765
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.06110203970213765
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00163132	0.06110203970213765
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.06110203970213765
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00163132	0.06110203970213765
14Q11.2 MICRODELETION SYNDROME	0.00163132	0.06110203970213765
MILROY DISEASE	0.00163132	0.06110203970213765
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.06110203970213765
PTERYGIUM COLLI, ISOLATED	0.00163132	0.06110203970213765
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.06110203970213765
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.06110203970213765
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.06110203970213765
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.06110203970213765
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00163132	0.06110203970213765
RING CHROMOSOME 8 SYNDROME	0.00163132	0.06110203970213765
MUCOLIPIDOSIS TYPE II	0.00163132	0.06110203970213765
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.04071320611599911
MEND SYNDROME	0.001086973	0.04071320611599911
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001086973	0.04071320611599911
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.04071320611599911
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.04071320611599911
JOUBERT SYNDROME WITH RENAL DEFECT	0.001086973	0.04071320611599911
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.04071320611599911
NARP SYNDROME	0.001086973	0.04071320611599911
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.04071320611599911
EAST SYNDROME	0.001086973	0.04071320611599911
PITT-HOPKINS SYNDROME	0.001086973	0.04071320611599911
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.04071320611599911
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.04071320611599911
SRD5A3-CDG	0.001086973	0.04071320611599911
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.04071320611599911
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.04071320611599911
15Q14 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
GRISCELLI SYNDROME	0.001086973	0.04071320611599911
ALSTRÖM SYNDROME	0.001086973	0.04071320611599911
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.04071320611599911
WILSON-TURNER SYNDROME	0.001086973	0.04071320611599911
MEVALONIC ACIDURIA	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.04071320611599911
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.04071320611599911
HARTNUP DISEASE	0.001086973	0.04071320611599911
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.04071320611599911
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04071320611599911
DONNAI-BARROW SYNDROME	0.001086973	0.04071320611599911
LEBER CONGENITAL AMAUROSIS	0.001086973	0.04071320611599911
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.04071320611599911
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.04071320611599911
PHACE SYNDROME	0.001086973	0.04071320611599911
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.04071320611599911
ISOVALERIC ACIDEMIA	0.001086973	0.04071320611599911
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.04071320611599911
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.04071320611599911
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.04071320611599911
HYDRANENCEPHALY	0.001086973	0.04071320611599911
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.04071320611599911
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001086973	0.04071320611599911
NETHERTON SYNDROME	0.001086973	0.04071320611599911
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.04071320611599911
DYSTONIA-APHONIA SYNDROME	0.001086973	0.04071320611599911
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.04071320611599911
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.04071320611599911
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.04071320611599911
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.04071320611599911
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.04071320611599911
CITRULLINEMIA TYPE II	0.001086973	0.04071320611599911
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.04071320611599911
WYBURN-MASON SYNDROME	0.001086973	0.04071320611599911
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.04071320611599911
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.04071320611599911
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.04071320611599911
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.04071320611599911
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.04071320611599911
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.04071320611599911
GALACTOSEMIA	0.001086973	0.04071320611599911
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.04071320611599911
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04071320611599911
L1 SYNDROME	0.001086973	0.04071320611599911
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.04071320611599911
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.04071320611599911
CEDNIK SYNDROME	0.001086973	0.04071320611599911
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.04071320611599911
JOUBERT SYNDROME	0.001086973	0.04071320611599911
RFT1-CDG	0.001086973	0.04071320611599911
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.04071320611599911
STT3A-CDG	0.001086973	0.04071320611599911
CRANIOPHARYNGIOMA	0.001086973	0.04071320611599911
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001086973	0.04071320611599911
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.04071320611599911
KBG SYNDROME	0.001086973	0.04071320611599911
SSR4-CDG	0.001086973	0.04071320611599911
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.04071320611599911
STT3B-CDG	0.001086973	0.04071320611599911
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.04071320611599911
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.04071320611599911
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.04071320611599911
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.04071320611599911
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.04071320611599911
MAPLE SYRUP URINE DISEASE	0.001086973	0.04071320611599911
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.04071320611599911
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.04071320611599911
SEVERE CANAVAN DISEASE	0.001086973	0.04071320611599911
INCONTINENTIA PIGMENTI	0.001086973	0.04071320611599911
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.04071320611599911
ALG11-CDG	0.001086973	0.04071320611599911
XP21 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.04071320611599911
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.04071320611599911
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.04071320611599911
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.04071320611599911
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.04071320611599911
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.04071320611599911
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.04071320611599911
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.04071320611599911
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.04071320611599911
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.04071320611599911
SCHIZENCEPHALY	0.001086973	0.04071320611599911
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.04071320611599911
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.04071320611599911
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.04071320611599911
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.04071320611599911
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.04071320611599911
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.04071320611599911
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.04071320611599911
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.04071320611599911
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.04071320611599911
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.04071320611599911
CODAS SYNDROME	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.04071320611599911
WALKER-WARBURG SYNDROME	0.001086973	0.04071320611599911
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.04071320611599911
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.04071320611599911
ARGININEMIA	0.001086973	0.04071320611599911
TIMOTHY SYNDROME; TS	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.04071320611599911
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.04071320611599911
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.04071320611599911
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.04071320611599911
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.04071320611599911
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.04071320611599911
WAISMAN SYNDROME; WSMN	0.001086973	0.04071320611599911
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.04071320611599911
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.04071320611599911
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.04071320611599911
MEND SYNDROME; MEND	0.001086973	0.04071320611599911
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.04071320611599911
COFFIN-SIRIS SYNDROME 5	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.04071320611599911
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.04071320611599911
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.04071320611599911
SULFOCYSTEINURIA	0.001086973	0.04071320611599911
MIRAGE SYNDROME; MIRAGE	0.001086973	0.04071320611599911
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.04071320611599911
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.04071320611599911
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.04071320611599911
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.04071320611599911
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.04071320611599911
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.04071320611599911
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.04071320611599911
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.04071320611599911
ALG1-CDG	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.04071320611599911
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.04071320611599911
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.04071320611599911
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.04071320611599911
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.04071320611599911
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.04071320611599911
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.04071320611599911
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.04071320611599911
GRISCELLI SYNDROME TYPE 1	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.04071320611599911
PFEIFFER SYNDROME TYPE 2	0.001086973	0.04071320611599911
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.04071320611599911
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.04071320611599911
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001086973	0.04071320611599911
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.04071320611599911
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.04071320611599911
MEHMO SYNDROME; MEHMO	0.001086973	0.04071320611599911
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.04071320611599911
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.04071320611599911
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.04071320611599911
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.04071320611599911
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.04071320611599911
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.04071320611599911
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.04071320611599911
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.04071320611599911
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.04071320611599911
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.04071320611599911
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.04071320611599911
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.04071320611599911
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.04071320611599911
KEUTEL SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.04071320611599911
LISSENCEPHALY 4	0.001086973	0.04071320611599911
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.04071320611599911
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.04071320611599911
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.04071320611599911
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.04071320611599911
GENITOPATELLAR SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.04071320611599911
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.04071320611599911
EMANUEL SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.04071320611599911
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.04071320611599911
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.04071320611599911
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.04071320611599911
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.04071320611599911
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.04071320611599911
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.04071320611599911
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.04071320611599911
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.04071320611599911
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.04071320611599911
HOLOPROSENCEPHALY 7	0.001086973	0.04071320611599911
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.04071320611599911
GLASS SYNDROME	0.001086973	0.04071320611599911
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.04071320611599911
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.04071320611599911
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.04071320611599911
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.04071320611599911
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.04071320611599911
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.04071320611599911
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.04071320611599911
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.04071320611599911
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.04071320611599911
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.04071320611599911
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001086973	0.04071320611599911
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.04071320611599911
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.04071320611599911
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.04071320611599911
PHACE ASSOCIATION	0.001086973	0.04071320611599911
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.04071320611599911
PROPIONIC ACIDEMIA	0.001086973	0.04071320611599911
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.04071320611599911
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.04071320611599911
SALLA DISEASE	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.04071320611599911
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.04071320611599911
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.04071320611599911
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.04071320611599911
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.04071320611599911
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.04071320611599911
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.04071320611599911
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.04071320611599911
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.04071320611599911
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.04071320611599911
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.04071320611599911
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.04071320611599911
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.04071320611599911
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.04071320611599911
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.04071320611599911
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.04071320611599911
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.04071320611599911
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.04071320611599911
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.04071320611599911
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.04071320611599911
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.04071320611599911
SIALIDOSIS TYPE 2	0.001086973	0.04071320611599911
LISSENCEPHALY 1; LIS1	0.001086973	0.04071320611599911
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.04071320611599911
LISSENCEPHALY 8; LIS8	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.04071320611599911
HARTNUP DISORDER	0.001086973	0.04071320611599911
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.04071320611599911
DIGEORGE SYNDROME; DGS	0.001086973	0.04071320611599911
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.001086973	0.04071320611599911
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.04071320611599911
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.04071320611599911
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.04071320611599911
VICI SYNDROME; VICIS	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.04071320611599911
ARGININOSUCCINIC ACIDURIA	0.001086973	0.04071320611599911
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.04071320611599911
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.04071320611599911
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001086973	0.04071320611599911
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.04071320611599911
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.04071320611599911
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.04071320611599911
INFANTILE REFSUM DISEASE	0.001086973	0.04071320611599911
KETOADIPICACIDURIA	0.001086973	0.04071320611599911
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.04071320611599911
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.04071320611599911
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.04071320611599911
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.04071320611599911
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.04071320611599911
MACDERMOT-WINTER SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.04071320611599911
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.04071320611599911
LANDAU-KLEFFNER SYNDROME	0.001086973	0.04071320611599911
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.04071320611599911
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.04071320611599911
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.04071320611599911
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.04071320611599911
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.04071320611599911
GAUCHER DISEASE, TYPE II	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.04071320611599911
DISTAL MONOSOMY 19P13.3	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.04071320611599911
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.04071320611599911
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.04071320611599911
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.04071320611599911
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.04071320611599911
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.04071320611599911
COACH SYNDROME	0.001086973	0.04071320611599911
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.04071320611599911
CLASSIC PHENYLKETONURIA	0.001086973	0.04071320611599911
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.04071320611599911
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.04071320611599911
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.04071320611599911
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.04071320611599911
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.04071320611599911
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.04071320611599911
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.04071320611599911
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.04071320611599911
CITRULLINEMIA, CLASSIC	0.001086973	0.04071320611599911
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.04071320611599911
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.04071320611599911
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.04071320611599911
KBG SYNDROME	0.001086973	0.04071320611599911
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.04071320611599911
PALLISTER-HALL SYNDROME	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.04071320611599911
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.04071320611599911
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.04071320611599911
VICI SYNDROME	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.04071320611599911
ALG3-CDG	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.04071320611599911
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.04071320611599911
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.04071320611599911
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.04071320611599911
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.04071320611599911
2P21 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
ELEJALDE DISEASE	0.001086973	0.04071320611599911
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.04071320611599911
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.04071320611599911
DISTAL MONOSOMY 15Q	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.04071320611599911
COFFIN-SIRIS SYNDROME 1; CSS1	0.001086973	0.04071320611599911
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.04071320611599911
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.04071320611599911
LEIGH SYNDROME; LS	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.04071320611599911
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.04071320611599911
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.04071320611599911
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.04071320611599911
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.04071320611599911
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.04071320611599911
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.04071320611599911
ANGELMAN SYNDROME	0.001086973	0.04071320611599911
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.04071320611599911
XQ21 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.04071320611599911
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.04071320611599911
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.04071320611599911
XQ28 (MECP2) DUPLICATION	0.001086973	0.04071320611599911
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.04071320611599911
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.04071320611599911
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.02043404247337126
JOUBERT SYNDROME 6	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.02043404247337126
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02043404247337126
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02043404247337126
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.02043404247337126
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.02043404247337126
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.02043404247337126
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.02043404247337126
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.02043404247337126
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.02043404247337126
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02043404247337126
HURLER SYNDROME	0.000545554	0.02043404247337126
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.02043404247337126
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.02043404247337126
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02043404247337126
SENIOR-LOKEN SYNDROME	0.000545554	0.02043404247337126
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.02043404247337126
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02043404247337126
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.02043404247337126
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.02043404247337126
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.02043404247337126
FRIED SYNDROME	0.000545554	0.02043404247337126
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.02043404247337126
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.02043404247337126
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.02043404247337126
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.02043404247337126
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02043404247337126
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.02043404247337126
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.02043404247337126
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.02043404247337126
SEPTOOPTIC DYSPLASIA	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02043404247337126
LIG4 SYNDROME	0.000545554	0.02043404247337126
FRIAS SYNDROME	0.000545554	0.02043404247337126
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02043404247337126
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.02043404247337126
CURRARINO SYNDROME	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02043404247337126
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02043404247337126
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.02043404247337126
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02043404247337126
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.02043404247337126
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02043404247337126
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02043404247337126
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02043404247337126
ALSTROM SYNDROME; ALMS	0.000545554	0.02043404247337126
ABETAL34V AMYLOIDOSIS	0.000545554	0.02043404247337126
MEVALONIC ACIDURIA; MEVA	0.000545554	0.02043404247337126
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02043404247337126
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.02043404247337126
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.02043404247337126
JOUBERT SYNDROME 2	0.000545554	0.02043404247337126
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02043404247337126
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.02043404247337126
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.02043404247337126
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02043404247337126
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.02043404247337126
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.02043404247337126
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.02043404247337126
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.02043404247337126
RIGID SPINE SYNDROME	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.02043404247337126
AUSTRALIA ANTIGEN	0.000545554	0.02043404247337126
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02043404247337126
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.02043404247337126
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.02043404247337126
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.02043404247337126
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02043404247337126
PELLAGRA-LIKE SYNDROME	0.000545554	0.02043404247337126
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02043404247337126
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.02043404247337126
WAARDENBURG-SHAH SYNDROME	0.000545554	0.02043404247337126
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02043404247337126
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02043404247337126
JOUBERT SYNDROME 7	0.000545554	0.02043404247337126
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.02043404247337126
300270 ADRENOMYODYSTROPHY	0.000545554	0.02043404247337126
JAWAD SYNDROME	0.000545554	0.02043404247337126
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02043404247337126
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.02043404247337126
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02043404247337126
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.02043404247337126
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02043404247337126
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.02043404247337126
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.02043404247337126
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02043404247337126
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.02043404247337126
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02043404247337126
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.02043404247337126
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.02043404247337126
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02043404247337126
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.02043404247337126
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.02043404247337126
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.02043404247337126
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02043404247337126
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02043404247337126
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.02043404247337126
MUCOLIPIDOSIS IV; ML4	0.000545554	0.02043404247337126
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.02043404247337126
OROTIC ACIDURIA	0.000545554	0.02043404247337126
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.02043404247337126
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02043404247337126
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02043404247337126
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.02043404247337126
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.02043404247337126
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02043404247337126
NAVAJO NEUROHEPATOPATHY	0.000545554	0.02043404247337126
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02043404247337126
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.02043404247337126
REVESZ SYNDROME	0.000545554	0.02043404247337126
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.02043404247337126
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.02043404247337126
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02043404247337126
NETHERTON SYNDROME; NETH	0.000545554	0.02043404247337126
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.02043404247337126
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02043404247337126
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02043404247337126
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02043404247337126
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02043404247337126
RIDDLE SYNDROME	0.000545554	0.02043404247337126
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02043404247337126
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.02043404247337126
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.02043404247337126
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.02043404247337126
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.02043404247337126
CURRY-JONES SYNDROME	0.000545554	0.02043404247337126
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02043404247337126
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.02043404247337126
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02043404247337126
CDAGS SYNDROME	0.000545554	0.02043404247337126
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.02043404247337126
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.02043404247337126
CONGENITAL HYPOTHYROIDISM	0.000545554	0.02043404247337126
FARBER DISEASE	0.000545554	0.02043404247337126
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.02043404247337126
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.02043404247337126
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.02043404247337126
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02043404247337126
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02043404247337126
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02043404247337126
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.02043404247337126
NOONAN SYNDROME 2; NS2	0.000545554	0.02043404247337126
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02043404247337126
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.02043404247337126
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02043404247337126
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337126
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02043404247337126
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.02043404247337126
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02043404247337126
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02043404247337126
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.02043404247337126
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02043404247337126
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.02043404247337126
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02043404247337126
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.02043404247337126
THYROID ECTOPIA	0.000545554	0.02043404247337126
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.02043404247337126
EPIDERMAL NEVUS SYNDROME	0.000545554	0.02043404247337126
ATHYREOSIS	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.02043404247337126
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02043404247337126
ARIMA SYNDROME	0.000545554	0.02043404247337126
PROPIONIC ACIDEMIA	0.000545554	0.02043404247337126
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.02043404247337126
YUNIS-VARON SYNDROME	0.000545554	0.02043404247337126
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.02043404247337126
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02043404247337126
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.02043404247337126
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.02043404247337126
THYROID HEMIAGENESIS	0.000545554	0.02043404247337126
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.02043404247337126
LOWRY-MACLEAN SYNDROME	0.000545554	0.02043404247337126
WEAVER SYNDROME	0.000545554	0.02043404247337126
THYROID HYPOPLASIA	0.000545554	0.02043404247337126
HYDROXYKYNURENINURIA	0.000545554	0.02043404247337126
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02043404247337126
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.02043404247337126
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02043404247337126
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.02043404247337126
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.02043404247337126
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02043404247337126
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02043404247337126
OPTIC ATROPHY 11; OPA11	0.000545554	0.02043404247337126
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.02043404247337126
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.02043404247337126
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.02043404247337126
ALAZAMI-YUAN SYNDROME	0.000545554	0.02043404247337126
JOUBERT SYNDROME 28	0.000545554	0.02043404247337126
JOUBERT SYNDROME 27	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.02043404247337126
MEIER-GORLIN SYNDROME 7	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.02043404247337126
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.02043404247337126
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
MARDEN-WALKER SYNDROME	0.000545554	0.02043404247337126
ALG6-CDG	0.000545554	0.02043404247337126
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02043404247337126
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.02043404247337126
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02043404247337126
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.02043404247337126
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.02043404247337126
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.02043404247337126
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.02043404247337126
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.02043404247337126
MEDULLOBLASTOMA	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.02043404247337126
MECKEL SYNDROME 13; MKS13	0.000545554	0.02043404247337126
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.02043404247337126
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02043404247337126
RAHMAN SYNDROME	0.000545554	0.02043404247337126
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.02043404247337126
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02043404247337126
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02043404247337126
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.02043404247337126
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.02043404247337126
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.02043404247337126
NOONAN SYNDROME 9; NS9	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.02043404247337126
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02043404247337126
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02043404247337126
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.02043404247337126
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.02043404247337126
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02043404247337126
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.02043404247337126
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.02043404247337126
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02043404247337126
JOUBERT SYNDROME 24	0.000545554	0.02043404247337126
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02043404247337126
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.02043404247337126
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.02043404247337126
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.02043404247337126
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02043404247337126
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.02043404247337126
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02043404247337126
JOUBERT SYNDROME 26	0.000545554	0.02043404247337126
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.02043404247337126
SECKEL SYNDROME 9; SCKL9	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.02043404247337126
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.02043404247337126
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02043404247337126
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02043404247337126
ATELOSTEOGENESIS TYPE III	0.000545554	0.02043404247337126
N SYNDROME	0.000545554	0.02043404247337126
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.02043404247337126
USHER SYNDROME TYPE 1	0.000545554	0.02043404247337126
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02043404247337126
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.02043404247337126
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.02043404247337126
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02043404247337126
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02043404247337126
TRANSALDOLASE DEFICIENCY	0.000545554	0.02043404247337126
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02043404247337126
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.02043404247337126
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.02043404247337126
NOONAN SYNDROME 11; NS11	0.000545554	0.02043404247337126
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.02043404247337126
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.02043404247337126
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.02043404247337126
COLE-CARPENTER SYNDROME	0.000545554	0.02043404247337126
RABSON-MENDENHALL SYNDROME	0.000545554	0.02043404247337126
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.02043404247337126
AURICULOCONDYLAR SYNDROME	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA	0.000545554	0.02043404247337126
DISTAL TRISOMY 6P	0.000545554	0.02043404247337126
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337126
DEXTROCARDIA	0.000545554	0.02043404247337126
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.02043404247337126
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.02043404247337126
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.02043404247337126
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337126
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02043404247337126
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337126
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02043404247337126
RING CHROMOSOME 12 SYNDROME	0.000545554	0.02043404247337126
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.02043404247337126
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.02043404247337126
WOLMAN DISEASE	0.000545554	0.02043404247337126
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02043404247337126
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02043404247337126
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.02043404247337126
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.02043404247337126
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.02043404247337126
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.02043404247337126
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.02043404247337126
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.02043404247337126
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.02043404247337126
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.02043404247337126
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.02043404247337126
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.02043404247337126
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.02043404247337126
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.02043404247337126
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02043404247337126
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02043404247337126
HYPERTRICHOSIS CUBITI	0.000545554	0.02043404247337126
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.02043404247337126
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.02043404247337126
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02043404247337126
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02043404247337126
HYDROXYKYNURENINURIA	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.02043404247337126
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02043404247337126
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.02043404247337126
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.02043404247337126
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.02043404247337126
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.02043404247337126
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.02043404247337126
JOUBERT SYNDROME 25	0.000545554	0.02043404247337126
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.02043404247337126
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.02043404247337126
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.02043404247337126
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02043404247337126
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.02043404247337126
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02043404247337126
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.02043404247337126
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.02043404247337126
CONGENITAL VARICELLA SYNDROME	0.000545554	0.02043404247337126
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02043404247337126
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02043404247337126
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337126
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.02043404247337126
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.02043404247337126
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02043404247337126
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.02043404247337126
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.02043404247337126
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.02043404247337126
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.02043404247337126
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.02043404247337126
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02043404247337126
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.02043404247337126
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02043404247337126
JOUBERT SYNDROME 15	0.000545554	0.02043404247337126
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.02043404247337126
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.02043404247337126
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.02043404247337126
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.02043404247337126
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.02043404247337126
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02043404247337126
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02043404247337126
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02043404247337126
JOUBERT SYNDROME 8	0.000545554	0.02043404247337126
OXOGLUTARIC ACIDURIA	0.000545554	0.02043404247337126
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02043404247337126
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.02043404247337126
SAY-BARBER-MILLER SYNDROME	0.000545554	0.02043404247337126
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.02043404247337126
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02043404247337126
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.02043404247337126
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.02043404247337126
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.02043404247337126
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02043404247337126
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.02043404247337126
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.02043404247337126
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02043404247337126
HOLOPROSENCEPHALY 11	0.000545554	0.02043404247337126
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02043404247337126
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02043404247337126
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02043404247337126
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.02043404247337126
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.02043404247337126
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02043404247337126
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.02043404247337126
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02043404247337126
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02043404247337126
TRANSKETOLASE DEFICIENCY	0.000545554	0.02043404247337126
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.02043404247337126
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02043404247337126
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02043404247337126
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.02043404247337126
SECKEL SYNDROME 8; SCKL8	0.000545554	0.02043404247337126
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.02043404247337126
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02043404247337126
XIA-GIBBS SYNDROME	0.000545554	0.02043404247337126
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.02043404247337126
CULLER-JONES SYNDROME; CJS	0.000545554	0.02043404247337126
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.02043404247337126
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.02043404247337126
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 2	0.000545554	0.02043404247337126
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02043404247337126
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.02043404247337126
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02043404247337126
JOUBERT SYNDROME 21	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02043404247337126
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337126
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.02043404247337126
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.02043404247337126
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02043404247337126
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.02043404247337126
LASSA FEVER	0.000541419	0.02027916364262785
INSULINOMA	0.000541419	0.02027916364262785
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.02027916364262785
ONDINE SYNDROME	0.000541419	0.02027916364262785
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02027916364262785
NIPAH VIRUS DISEASE	0.000541419	0.02027916364262785
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.02027916364262785
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.02027916364262785
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.02027916364262785
47,XYY SYNDROME	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.02027916364262785
WHIM SYNDROME	0.000541419	0.02027916364262785
SECONDARY SYRINGOMYELIA	0.000541419	0.02027916364262785
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.02027916364262785
PFEIFFER SYNDROME TYPE 3	0.000541419	0.02027916364262785
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.02027916364262785
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.02027916364262785
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.02027916364262785
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02027916364262785
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.02027916364262785
SANDHOFF DISEASE	0.000541419	0.02027916364262785
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.02027916364262785
PORPHYRIA	0.000541419	0.02027916364262785
SCLERODERMA	0.000541419	0.02027916364262785
GRISCELLI SYNDROME TYPE 2	0.000541419	0.02027916364262785
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.02027916364262785
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.02027916364262785
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.02027916364262785
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.02027916364262785
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.02027916364262785
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.02027916364262785
RABIES	0.000541419	0.02027916364262785
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.02027916364262785
FETAL GAUCHER DISEASE	0.000541419	0.02027916364262785
DERMOTRICHIC SYNDROME	0.000541419	0.02027916364262785
ANGELMAN SYNDROME	0.000541419	0.02027916364262785
MEHMO SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.02027916364262785
FAMILIAL THROMBOCYTOSIS	0.000541419	0.02027916364262785
ADRENOMYODYSTROPHY	0.000541419	0.02027916364262785
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.02027916364262785
FRAGILE X SYNDROME	0.000541419	0.02027916364262785
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02027916364262785
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.02027916364262785
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02027916364262785
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.02027916364262785
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.02027916364262785
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.02027916364262785
MYASTHENIA GRAVIS	0.000541419	0.02027916364262785
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02027916364262785
ALG2-CDG	0.000541419	0.02027916364262785
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.02027916364262785
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.02027916364262785
MPDU1-CDG	0.000541419	0.02027916364262785
OCULOCEREBRORENAL SYNDROME OF LOWE	0.000541419	0.02027916364262785
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.02027916364262785
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.02027916364262785
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02027916364262785
DPM1-CDG	0.000541419	0.02027916364262785
SJÖGREN-LARSSON SYNDROME	0.000541419	0.02027916364262785
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.02027916364262785
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.02027916364262785
CAMOS SYNDROME	0.000541419	0.02027916364262785
SCRUB TYPHUS	0.000541419	0.02027916364262785
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.02027916364262785
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.02027916364262785
PARTINGTON SYNDROME	0.000541419	0.02027916364262785
CENTRONUCLEAR MYOPATHY	0.000541419	0.02027916364262785
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02027916364262785
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.02027916364262785
ISOLATED SPINA BIFIDA	0.000541419	0.02027916364262785
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.02027916364262785
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.02027916364262785
ENCEPHALITIS LETHARGICA	0.000541419	0.02027916364262785
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.02027916364262785
SYSTEMIC SCLEROSIS	0.000541419	0.02027916364262785
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.02027916364262785
LHERMITTE-DUCLOS DISEASE	0.000541419	0.02027916364262785
LEIGH SYNDROME	0.000541419	0.02027916364262785
DEND SYNDROME	0.000541419	0.02027916364262785
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02027916364262785
EPISODIC ATAXIA TYPE 3	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.02027916364262785
PORPHYRIA VARIEGATA	0.000541419	0.02027916364262785
NEVUS COMEDONICUS SYNDROME	0.000541419	0.02027916364262785
RECURRENT ACUTE PANCREATITIS	0.000541419	0.02027916364262785
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.02027916364262785
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.02027916364262785
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.02027916364262785
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.02027916364262785
LIPOID PROTEINOSIS	0.000541419	0.02027916364262785
ADDISON DISEASE	0.000541419	0.02027916364262785
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.02027916364262785
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02027916364262785
HEREDITARY COPROPORPHYRIA	0.000541419	0.02027916364262785
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.02027916364262785
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.02027916364262785
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.02027916364262785
MOGS-CDG	0.000541419	0.02027916364262785
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.02027916364262785
ALG9-CDG	0.000541419	0.02027916364262785
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.02027916364262785
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.02027916364262785
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02027916364262785
KALLMANN SYNDROME	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.02027916364262785
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.02027916364262785
CYCLIC VOMITING SYNDROME	0.000541419	0.02027916364262785
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.02027916364262785
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.02027916364262785
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.02027916364262785
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.02027916364262785
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.02027916364262785
GURRIERI SYNDROME	0.000541419	0.02027916364262785
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.02027916364262785
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02027916364262785
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.02027916364262785
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.02027916364262785
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02027916364262785
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.02027916364262785
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.02027916364262785
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.02027916364262785
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02027916364262785
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.02027916364262785
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02027916364262785
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.02027916364262785
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.02027916364262785
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.02027916364262785
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.02027916364262785
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.02027916364262785
ALZHEIMER DISEASE 3; AD	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.02027916364262785
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.02027916364262785
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02027916364262785
ADRENOLEUKODYSTROPHY	0.000541419	0.02027916364262785
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.02027916364262785
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.02027916364262785
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.02027916364262785
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.02027916364262785
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02027916364262785
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.02027916364262785
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.02027916364262785
IMMUNODEFICIENCY 47	0.000541419	0.02027916364262785
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.02027916364262785
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.02027916364262785
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.02027916364262785
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.02027916364262785
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02027916364262785
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.02027916364262785
INCONTINENTIA PIGMENTI; IP	0.000541419	0.02027916364262785
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.02027916364262785
MENKES DISEASE	0.000541419	0.02027916364262785
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.02027916364262785
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.02027916364262785
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.02027916364262785
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.02027916364262785
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02027916364262785
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.000541419	0.02027916364262785
PERRAULT SYNDROME 3	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.02027916364262785
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.02027916364262785
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.02027916364262785
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02027916364262785
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.02027916364262785
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.02027916364262785
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.02027916364262785
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.02027916364262785
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.02027916364262785
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.02027916364262785
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.02027916364262785
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.02027916364262785
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.02027916364262785
COWDEN SYNDROME 5; CWS5	0.000541419	0.02027916364262785
COWDEN SYNDROME 6; CWS6	0.000541419	0.02027916364262785
LISSENCEPHALY 5; LIS5	0.000541419	0.02027916364262785
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02027916364262785
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.02027916364262785
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.02027916364262785
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.02027916364262785
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02027916364262785
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.02027916364262785
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.02027916364262785
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.02027916364262785
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.02027916364262785
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.02027916364262785
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.02027916364262785
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.02027916364262785
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.02027916364262785
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02027916364262785
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.02027916364262785
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02027916364262785
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.02027916364262785
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.02027916364262785
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02027916364262785
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.02027916364262785
LISSENCEPHALY 3; LIS3	0.000541419	0.02027916364262785
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.02027916364262785
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.02027916364262785
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02027916364262785
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.02027916364262785
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.02027916364262785
EPISODIC ATAXIA, TYPE 6	0.000541419	0.02027916364262785
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.02027916364262785
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.02027916364262785
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.02027916364262785
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.02027916364262785
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.02027916364262785
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.02027916364262785
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.02027916364262785
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.02027916364262785
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02027916364262785
STURGE-WEBER SYNDROME	0.000541419	0.02027916364262785
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.02027916364262785
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.02027916364262785
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.02027916364262785
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02027916364262785
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.02027916364262785
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.02027916364262785
AUTISM	0.000541419	0.02027916364262785
BANGSTAD SYNDROME	0.000541419	0.02027916364262785
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02027916364262785
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.02027916364262785
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.02027916364262785
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.02027916364262785
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.02027916364262785
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.02027916364262785
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.02027916364262785
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.02027916364262785
COCKAYNE SYNDROME A; CSA	0.000541419	0.02027916364262785
COHEN SYNDROME	0.000541419	0.02027916364262785
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.02027916364262785
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.02027916364262785
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02027916364262785
CROME SYNDROME	0.000541419	0.02027916364262785
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.02027916364262785
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.02027916364262785
DIAMINOPENTANURIA	0.000541419	0.02027916364262785
SNEDDON SYNDROME	0.000541419	0.02027916364262785
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.02027916364262785
PARIETAL FORAMINA	0.000541419	0.02027916364262785
1P36 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.02027916364262785
2Q33.1 DELETION SYNDROME	0.000541419	0.02027916364262785
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.02027916364262785
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.02027916364262785
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02027916364262785
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.02027916364262785
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.02027916364262785
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.02027916364262785
PAPILLORENAL SYNDROME	0.000541419	0.02027916364262785
CROUZON SYNDROME	0.000541419	0.02027916364262785
DARIER-WHITE DISEASE; DAR	0.000541419	0.02027916364262785
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.02027916364262785
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.02027916364262785
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02027916364262785
EPILEPSY, READING	0.000541419	0.02027916364262785
FLYNN-AIRD SYNDROME	0.000541419	0.02027916364262785
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02027916364262785
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.02027916364262785
HUNTINGTON DISEASE; HD	0.000541419	0.02027916364262785
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02027916364262785
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.02027916364262785
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.02027916364262785
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02027916364262785
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02027916364262785
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.02027916364262785
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.02027916364262785
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02027916364262785
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.02027916364262785
EPILEPSY-TELANGIECTASIA	0.000541419	0.02027916364262785
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.02027916364262785
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02027916364262785
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.02027916364262785
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.02027916364262785
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.02027916364262785
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.02027916364262785
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.02027916364262785
NEURAMINIDASE DEFICIENCY	0.000541419	0.02027916364262785
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.02027916364262785
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02027916364262785
PHENYLKETONURIA	0.000541419	0.02027916364262785
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.02027916364262785
GITELMAN SYNDROME	0.000541419	0.02027916364262785
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.02027916364262785
RAMON SYNDROME	0.000541419	0.02027916364262785
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02027916364262785
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.02027916364262785
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.02027916364262785
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.02027916364262785
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.02027916364262785
TAY-SACHS DISEASE; TSD	0.000541419	0.02027916364262785
THREONINEMIA	0.000541419	0.02027916364262785
THYROCEREBRORETINAL SYNDROME	0.000541419	0.02027916364262785
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.02027916364262785
XYLOSIDASE DEFICIENCY	0.000541419	0.02027916364262785
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.02027916364262785
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.02027916364262785
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.02027916364262785
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.02027916364262785
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.02027916364262785
FOUNTAIN SYNDROME	0.000541419	0.02027916364262785
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02027916364262785
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02027916364262785
GAPO SYNDROME; GAPOS	0.000541419	0.02027916364262785
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.02027916364262785
BERNARD-SOULIER SYNDROME	0.000541419	0.02027916364262785
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.02027916364262785
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.02027916364262785
HYPER-BETA-ALANINEMIA	0.000541419	0.02027916364262785
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.02027916364262785
HYPERLYSINEMIA, TYPE I	0.000541419	0.02027916364262785
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02027916364262785
HYPERPROLINEMIA, TYPE II	0.000541419	0.02027916364262785
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02027916364262785
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02027916364262785
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.02027916364262785
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.02027916364262785
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02027916364262785
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02027916364262785
KAPUR-TORIELLO SYNDROME	0.000541419	0.02027916364262785
KEUTEL SYNDROME; KTLS	0.000541419	0.02027916364262785
KIFAFA SEIZURE DISORDER	0.000541419	0.02027916364262785
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02027916364262785
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.02027916364262785
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.02027916364262785
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.02027916364262785
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02027916364262785
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.02027916364262785
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.02027916364262785
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.02027916364262785
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.02027916364262785
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.02027916364262785
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02027916364262785
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02027916364262785
EPENDYMOMA	0.000541419	0.02027916364262785
SUBEPENDYMOMA	0.000541419	0.02027916364262785
PINEOBLASTOMA	0.000541419	0.02027916364262785
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.000541419	0.02027916364262785
MICROSPORIDIOSIS	0.000541419	0.02027916364262785
MOYAMOYA DISEASE	0.000541419	0.02027916364262785
MOYNAHAN SYNDROME	0.000541419	0.02027916364262785
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02027916364262785
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.02027916364262785
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.02027916364262785
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.02027916364262785
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.02027916364262785
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02027916364262785
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.02027916364262785
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02027916364262785
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.02027916364262785
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.02027916364262785
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.02027916364262785
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.02027916364262785
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02027916364262785
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02027916364262785
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.02027916364262785
TYROSINEMIA TYPE 2	0.000541419	0.02027916364262785
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.02027916364262785
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
JUVENILE HUNTINGTON DISEASE	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.02027916364262785
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.02027916364262785
EPISODIC ATAXIA TYPE 6	0.000541419	0.02027916364262785
HARROD SYNDROME	0.000541419	0.02027916364262785
CYSTATHIONINURIA	0.000541419	0.02027916364262785
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02027916364262785
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02027916364262785
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02027916364262785
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.000541419	0.02027916364262785
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.02027916364262785
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.02027916364262785
CONGENITAL HYDROCEPHALUS	0.000541419	0.02027916364262785
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.02027916364262785
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02027916364262785
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.02027916364262785
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.02027916364262785
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.02027916364262785
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.02027916364262785
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02027916364262785
KABUKI SYNDROME	0.000541419	0.02027916364262785
SANJAD-SAKATI SYNDROME	0.000541419	0.02027916364262785
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.02027916364262785
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.02027916364262785
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02027916364262785
4Q21 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.000541419	0.02027916364262785
LOWRY-MACLEAN SYNDROME	0.000541419	0.02027916364262785
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.02027916364262785
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.02027916364262785
CONGENITAL RUBELLA SYNDROME	0.000541419	0.02027916364262785
CRONKHITE-CANADA SYNDROME	0.000541419	0.02027916364262785
PORENCEPHALY	0.000541419	0.02027916364262785
PROLACTINOMA	0.000541419	0.02027916364262785
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.02027916364262785
WORSTER-DROUGHT SYNDROME	0.000541419	0.02027916364262785
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.02027916364262785
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02027916364262785
GALACTOSIALIDOSIS	0.000541419	0.02027916364262785
GM1 GANGLIOSIDOSIS	0.000541419	0.02027916364262785
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.02027916364262785
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02027916364262785
GLIOBLASTOMA	0.000541419	0.02027916364262785
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02027916364262785
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.02027916364262785
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.02027916364262785
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.02027916364262785
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.02027916364262785
CLASSIC HOMOCYSTINURIA	0.000541419	0.02027916364262785
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.02027916364262785
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.02027916364262785
HYPERPROLINEMIA TYPE 1	0.000541419	0.02027916364262785
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.02027916364262785
HYPOPHOSPHATASIA	0.000541419	0.02027916364262785
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.02027916364262785
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.02027916364262785
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.02027916364262785
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.02027916364262785
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.02027916364262785
SLC39A8-CDG	0.000541419	0.02027916364262785
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.02027916364262785
VIRAL HEMORRHAGIC FEVER	0.000541419	0.02027916364262785
TRISOMY 13	0.000541419	0.02027916364262785
LUJO HEMORRHAGIC FEVER	0.000541419	0.02027916364262785
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.02027916364262785
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.02027916364262785
DDOST-CDG	0.000541419	0.02027916364262785
RAMON SYNDROME	0.000541419	0.02027916364262785
ISOLATED BILIARY ATRESIA	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02027916364262785
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.02027916364262785
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.02027916364262785
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.02027916364262785
NOCARDIOSIS	0.000541419	0.02027916364262785
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.02027916364262785
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.02027916364262785
EBOLA HEMORRHAGIC FEVER	0.000541419	0.02027916364262785
THYROCEREBRORENAL SYNDROME	0.000541419	0.02027916364262785
RIFT VALLEY FEVER	0.000541419	0.02027916364262785
HEREDITARY HYPEREKPLEXIA	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.02027916364262785
STURGE-WEBER SYNDROME	0.000541419	0.02027916364262785
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.02027916364262785
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.02027916364262785
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.02027916364262785
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.02027916364262785
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.02027916364262785
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.02027916364262785
TAKAYASU ARTERITIS	0.000541419	0.02027916364262785
MERCURY POISONING	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02027916364262785
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02027916364262785
CRIGLER-NAJJAR SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.02027916364262785
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.02027916364262785
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.02027916364262785
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.02027916364262785
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.02027916364262785
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02027916364262785
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.02027916364262785
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.02027916364262785
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02027916364262785
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.02027916364262785
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.02027916364262785
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02027916364262785
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.02027916364262785
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.02027916364262785
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.02027916364262785
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.02027916364262785
ATAXIA-TELANGIECTASIA	0.000541419	0.02027916364262785
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.02027916364262785
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02027916364262785
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.02027916364262785
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.02027916364262785
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.02027916364262785
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02027916364262785
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02027916364262785
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.02027916364262785
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.02027916364262785
TENORIO SYNDROME; TNORS	0.000541419	0.02027916364262785
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.02027916364262785
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.02027916364262785
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.02027916364262785
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.02027916364262785
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.02027916364262785
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.02027916364262785
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.02027916364262785
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.02027916364262785
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.02027916364262785
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.02027916364262785
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02027916364262785
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.02027916364262785
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.02027916364262785
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.02027916364262785
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.02027916364262785
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.02027916364262785
PSEUDO-TORCH SYNDROME 2	0.000541419	0.02027916364262785
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.02027916364262785
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.02027916364262785
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02027916364262785
CRYPTOCOCCOSIS	0.000541419	0.02027916364262785
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.02027916364262785
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.02027916364262785
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.02027916364262785
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.02027916364262785
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.02027916364262785
ROSAÏ-DORFMAN DISEASE	0.000541419	0.02027916364262785
2Q24 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02027916364262785
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02027916364262785
DISTAL TRISOMY 15Q	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.02027916364262785
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.02027916364262785
FAMILIAL DYSAUTONOMIA	0.000541419	0.02027916364262785
DYSEQUILIBRIUM SYNDROME	0.000541419	0.02027916364262785
CENTRAL DIABETES INSIPIDUS	0.000541419	0.02027916364262785
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.02027916364262785
COCKAYNE SYNDROME	0.000541419	0.02027916364262785
FRONTAL ENCEPHALOCELE	0.000541419	0.02027916364262785
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.02027916364262785
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.02027916364262785
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.02027916364262785
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02027916364262785
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.02027916364262785
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.02027916364262785
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.02027916364262785
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.02027916364262785
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.02027916364262785
CRISPONI SYNDROME	0.000541419	0.02027916364262785
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.02027916364262785
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02027916364262785
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02027916364262785
ROMANO-WARD SYNDROME	0.000541419	0.02027916364262785
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.02027916364262785
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.02027916364262785
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.02027916364262785
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02027916364262785
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02027916364262785
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.02027916364262785
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.02027916364262785
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.02027916364262785
BETA-MANNOSIDOSIS	0.000541419	0.02027916364262785
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.02027916364262785
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.02027916364262785
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.02027916364262785
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.02027916364262785
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.02027916364262785
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02027916364262785
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.02027916364262785
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.02027916364262785
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.02027916364262785
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.02027916364262785
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.02027916364262785
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.02027916364262785
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.02027916364262785
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.02027916364262785
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02027916364262785
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.000541419	0.02027916364262785
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02027916364262785
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.02027916364262785
